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Chronic pain is a common problem leading to a high individual and societal burden.
A cross sectional survey amongst adults revealed that chronic pain was present in 17% of
males and 20% of females 1, whilst self reported chronic pain was present in some 46% of
the general population 2. Low back pain (LBP) constitutes a major part of all chronic pain
problems. Its incidence with and without radiation to the lower limbs is 11,6 and 28,0 per
1000 patients referred to the general physician per year, respectively 3. In the Netherlands 
year prevalences of up to 40% of the total adult population are reported. Of all patients
having acute LBP, about 10% develop chronic back problems 4-6. No specific diagnosis, such
as a herniated disc or spinal stenosis, is found in more than 90% of all cases of low back pain.
Diagnosis and treatment in this patient population are laborious and problematic.
Once patients have chronic low back complaints they rarely recover, and 32% are unable 
to work at all 3.
Chronic (low back) pain: a complex problem
Since the mid 20th century there has been increasing attention to the idea that chronic
pain is multifactorially determined. Thus a multidisciplinary approach has been advocated
to improve treatment outcome. At present, the bio-psycho-social approach 7 is considered
the basis for the treatment of chronic low pain, which should be considered as a disease 
of itself 8. In most pain centers, at least 3 different disciplines representing psychologists,
neurologists, surgeons, anesthesiologists, physical therapists and rehabilitation physicians
are involved in the treatment of chronic pain. Multiple factors such as psychological, social,
behavioral, cultural, physical and economical factors are assessed to diagnose and treat 
chronic pain patients, whose problems are often complex. Recently, increasingly biological 
factors contributing to the complexity of the pain problem have been identified, such as 
pain and time induced functional changes of the central and peripheral nervous system, i.e.,
neuroplasticity 9, neuronal networks 10, and involvement of the (neuro-)immune system and
inflammatory processes 11. New diagnostic techniques like neurofunctional imaging 12,
quantitative sensory testing 13 (QST) and sophisticated spinal endoscopic procedures 14,15 are
helping us to develop further insights into the complex problem of pain and specifically into
the problem of LBP and its chronification.
Most LBP patients are treated by general practioners, usually according to the guide-
lines of their professional societies 16,17. In most patients with non-specific back complaints,
the problems will disappear spontaneously 18 and therefore initial additional investigation 
by general practitioners is discouraged. Thus LBP patients are most commonly treated 
conservatively using education, physical therapy, and oral medication. Patients with a more
chronic or recurrent course of LBP are referred to medical specialists such as neurologists,
orthopedic surgeons or rehabilitation medicine physicians. In severe cases chronic patients
are referred to multidisciplinary pain clinics for further assessment. If the diagnosis in patients
with chronic low back pain radiating to the leg (CLBP-r) is not clear despite extensive 
physical, neurological, orthopedic and radiological examination, “precision diagnosis”, such
as diagnostic facet blocks, sacroiliac joint blocks, diagnostic disc injections and segmental
nerve root blocks (SNRBs) has been advocated 19.
1.2
Segmental Nerve Root Blocks
Segmental Nerve Root Blocks (SNRBs), also known as nerve root sheath infiltration
or periradicular nerve root injection, have been employed since the early thirties of the 
last century. They are typically done for diagnostic purposes in patients with radicular pain
to determine the pain conducting spinal segment prior to surgery 20-25, to identify the 
putative symptomatic level for diagnostic reasons in patients with pain presenting as radicular
but not fully concordant with the radiological diagnosis 26-28, and to select patients for a 
radio-frequency procedure of a dorsal root ganglion 29-31 (RF-DRG). Furthermore, SNRBs
with local anaesthetics have been followed by or combined with corticosteroid agents 32,33
for diagnostic and therapeutic reasons.
However, SNRBs are not mentioned as an additional diagnostic step in the guidelines
on lumbosacral radicular syndrome for general practitioners 16. As already mentioned, further
diagnostic assessment is in fact discouraged in case of non-specific low back complaints 17,34.
Non-specific or aspecific LBP is an accumulation of complaints after specific diagnoses such
as a herniated disc, spinal stenosis, infection or tumour have been excluded or if indications
for their presence cannot be found. Nevertheless, other diagnostic entities as underlying 
cause of pain in CLBP-r patients 19 have been suggested, such as syndromes related to the
lumbosacral facet joints, lumbar discs and sacroiliac joints. Imaging techniques commonly do
not bring about a diagnostic classification in these patients, either, and therefore “precision
diagnosis” is frequently suggested to further establish a diagnosis 19,26,31. For this reason, when
CLBP radiates to the leg according to a dermatomal pattern in the context of non-concor-
dance of radiological diagnosis and pain presentation, SNRBs are commonly advocated.
Problems with SNRBs
There are many uncertainties with respect to the diagnostic value of SNRBs. One of the
fundamental problems in CLBP-r patients is that pain reduction after SNRB may not inform
us about cause and source of the pain, in contrast to a specific radicular pain syndrome where
surgery and subsequent pain relief can confirm SNRB-aided diagnosis retrospectively.
Thus, one of the main questions in this context is how one should interpret pain reduction
with SNRB in CLBP-r patients with an uncertain underlying diagnosis. The justification for
the use of SNRBs is based upon the axiom that pain reduction after blocking a particular
spinal segmental nerve root indicates that this nerve root plays an essential role in the 
pain-conducting pathway. This is surprising, since SNRB outcome in CLBP-r patients lacks
a gold standard upon which to base such a supposition 35.
Gold standard
A gold standard is a conclusive test or type of information that distinguishes patients
having a disease or not. The ideal gold standard diagnoses the problem with 100% accuracy.
A diagnostic test is considered reliable if it has a high sensitivity (ratio indicating the 
persons positive for the test related to persons who really do have the disease) and a high
specificity (ratio indicating the persons negative for the test related to those who do not have
the disease). The gold standard for validating SNRB effect in patients with specific radicular
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pain, e.g. a herniated disc with nerve root compression diagnosed by history, clinical exami-
nation and MRI, is an accurate and specific anatomical and functional diagnosis followed
by abolition of the patient’s pain after surgical repair of the previously diagnosed prolapsed
disc with relief of nerve compression in that patient. If an anatomical diagnostic gold 
standard is not available, which is the case in CLBP-r patients who have no clear diagnosis,
at least a functional diagnostic gold standard, i.e. an objectively quantifiable disorder of pain
system function should be present. In the case of SNRB, the underlying rationale would 
be that functional block of the disordered segment of the pain system results in reduction 
– or abolition – of pain symptoms. If SNRBs were a sensitive and specific diagnostic test,
all SNRB-positive patients should together form a homogeneous population with respect 
to anatomical or functional diagnosis. CLBP-r patients, however, do not seem to form 
such a homogeneous population and we thus lack a gold standard upon which to base 
interpretation SNRB effects to compare with.
Further, if SNRB are applied to a heterogeneous population, its effects should at 
least be reproducible, i.e. consistent, leaving only the outcome variable. The outcome should
distinguish patients with spinal segment related radiating pain in a reliable fashion from
patients without segmental related radiating pain. This means that in case of applying SNRBs,
the blocking effect on the segmental nerve roots should be consistent and predictable.
To assess consistency of effects, SNRB induced changes in sensory and motor function 
should be measured. If these blocking effects indeed are reliably and predictably consistent,
SNRB can be considered a useful diagnostic tool in CLBP-r patients.
Diagnostic value of SNRBs
Hildebrand (36) postulated that the diagnostic value of nerve blocks rests on 3 
premises. Firstly, causal pathology is located at an exact and defined peripheral location.
Secondly, injection of a local anaesthetic will abolish only the sensory function of the target
neuronal location. Thirdly, pain relief subsequent to a local anaesthetic injection is attribu-
table solely to the nerve block. The first premise raises problems in CLBP-r patients because
the exact causal pathology is often not known and a diagnostic gold standard to compare
with is absent. With respect to the second premise, the sensory selectivity of the SNRB is
questioned 37. The last premise may be tested by repeating the SNRB and by comparing the
effects with blocks at neighbouring levels. Thus SNRBs, in reality, do not fulfill Hildebrand’s
criteria either. In patients, no relevant data are available on the relationship between volume,
dosage of local anaesthetics and their effects. Despite all these uncertainties, i.e., we neither
know what we are blocking nor do we understand the variability with respect to patients and
blocking technique, SNRBs are assumed to produce predictive information regarding sensory
and motor function within the segmental innervation territory, i.e., the corresponding 
dermatome and myotome respectively. Up to now no studies have appeared to describe 
these effects systematically in CLBP-r patients.
Lumbosacral Segmental Nerve Root Block Technique
To locate the target spinal nerve, a needle is inserted under CT or fluoroscopy 
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guidance towards the intended nerve root or its DRG. Correct anatomical position is 
assumed when the tip of the electrode is in the dorsocranial quadrant of the intervertebral
foramen lateral to the medial half of the adjacent pedicles. Correct functional position of
the needle is achieved by redirection of the needle and is assumed when, with the proper 
stimulation criteria, electrical or mechanical nerve stimulation elicits paraesthesias in the
corresponding dermatome. Recently, the use of nerve stimulation after SNRB as well has
been suggested in order to match patterns of pain and elicited paraesthesias 38. Next, a small
volume of contrast dye (0.5-1.0 ml) is injected to confirm needle tip position. Finally, a small
volume of local anaesthetic is applied locally, which should reduce the radiating pain. There
is no consensus in the literature as to what amount of pain reduction should be considered
significant with SNRB. Pain reductions between 30% and 100% are commonly used. Also,
hypoaesthesia or anaesthesia in the related dermatome is expected to develop as result of
partial or even complete block of the afferent pathways. SNRBs should be selective at the
same time. In order to act on sensory pathways as much as possible, the local anaesthetic
needs to be restricted to the target spinal sensory nerve root or DRG by limiting injection 
to the intervertebral foramen. Both the position of the tip of the electrode and the use of a
small amount of local anaesthetic are assumed to prevent (or reduce) blockade of motor
fibers in the anterior root and of adjacent spinal nerve roots via extraforaminal spread.
This combination of conditions is important because SNRB induced paresis/paralysis may
attenuate pain provocation by hindering adequate use of the affected leg by the patient. If
the tip of the electrode is positioned more laterally in the intervertebral foramen or outside
the foramen, paresis/paralysis may develop as consequence of a motor axon conduction block
in the mixed spinal nerve. However, we do know from our own experience that many patients
report reduction of muscle strength in their leg on the painful side, despite SNRBs being
applied intraforaminally. This, again, suggests that much of the data on SNRB is based upon
assumptions and that the relationship between SNRB effects on pain and motor function
needs further elucidation.
Background to this thesis
At the beginning of the studies presented in this thesis, we realized that it is actually
not known if a SNRB is a consistent entity, despite it having been used for many years.
Indeed, the reliability and selectivity of SNRBs 37,39 continues to be debated. Furthermore, the
specificity of SNRBs even in sciatica is questioned 40. To determine any sensitivity and speci-
ficity a gold standard is needed. For SNRBs in specific radicular pain syndromes in which a
cause can be objectively and reliably identified, findings at surgery may be considered as gold
standard, in which MRI and CT can be supportive but not conclusive. Unfortunately, as 
already discussed, such a gold standard is lacking for non-specific radiating pain, in which no
direct cause can be reliably and objectively identified. This is often the case in the CLBP-r
patient population that is referred to pain specialists for further diagnosis. Tests such as EMG,
CT or MRI only have a weak relationship with pain, and surgery, by which a more specific 
diagnosis could be made, is generally not indicated. Recent techniques to visualize putative
symptomatic nerve roots, such as spinal endoscopy, might prove to be of help in this regard.
1.5
Aims of this thesis
A simple description limited to the effect of SNRBs on the patients’ pain does not
bring us further in understanding the value of these blocks. Thus, we need to focus on the
accompanying objectifiable and quantifiable clinical and physiological effects of SNRBs.
Therefore, we started by systematically mapping and documenting the paraesthesias elicited
by electrostimulation, and the hypoaesthesia and changes in muscle force induced by SNRB.
Further, we studied the variability and consistency of these effects in relationship to pain and
pain reduction and assessed their mutual relationships to better comprehend the diagnostic
role of SNRBs in CLBP-r patients without an unequivocal anatomical and functional 
diagnosis. Various other issues regarding technical and pharmacological aspects may also be
relevant for the assessment of the variability and consistency of SNRB effects.
We were not able to study all of these aspects, but we did document the epidural 
spread of the injected agent as one factor that is quite simple to assess in clinical practice.
Improved insight into the value of SNRBs should bring us further in understanding 
underlying pain mechanisms, which is essential to raise efficacy of pain treatment in 
CLBP-r patients.
Thus, the key points with respect to SNRBs in CLBP-r patients are:
• CLBP-r patients, forming together a large population, lack an equivocal anatomical and
functional diagnosis.
• SNRBs are used with the aim of improving diagnosis in these patients.
• In CLBP-r patients there is no anatomical and no functional gold standard with which to
compare SNRB diagnosis.
• Thus: is the SNRB a defined tool to diagnose segmental pain in CLBP-r patients?
Subsequently, we can summarize the main questions addressed by this thesis:
1) What is the present basis for the application of SNRBs in CLBP-r patients? (chapter 2)
2) Are SNRB effects expressed in a dermatome-related fashion? (chapter 3)
3) Do SNRBs exert consistent effects on sensory function? (chapter 4)
4) Do SNRBs exert consistent effects on motor function? (chapter 5)
5) Is there any role for SNRBs as a diagnostic tool in CLBP-r patients? (chapter 6)
In chapter 2 a survey of the present knowledge regarding the background of SNRBs
and its diagnostic value in CLBP-r patients without overt neurological deficits is given.
In chapter 3 we describe an observational prospective double blind study on the 
variability and interpretation of SNRB effects on sensory function. Pinprick is used to assess
post block dermatomal related hypoaesthesia after lumbosacral SNRBs in CLBP-r patients
without overt neurological deficits. Sites with maximum experienced pain, pre-block elicited
paraesthesias, and local anaesthetic induced hypoaesthesia are compared between standard
and extended dermatomes, which display the overlap with neighbouring dermatomes.
In chapter 4 we present a case series of CLBP-r patients undergoing L4 SNRBs with
lidocaine and ropivacaine in a prospective randomised crossover fashion. We describe 
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changes in pre- and post block extent and location of hypoesthesia that occurred related to
the blocks.
Chapter 5 conveys a prospective randomised crossover study concerning the 
SNRB effects of lidocaine and ropivacaine in CLBP-r patients on pain and muscle force.
We compare pain reduction with changes in maximum voluntary myotomal muscle force
to assess mutual interactions.
In chapter 6 we describe a prospective observational study performed to evaluate the
spread of fluoroscopy controlled contrast dye that was added to the local anaesthetic agent
injected with lumbosacral SNRB. Fluoroscopy is commonly used in pain practices to guide
invasive diagnosis. Inadvertent spread of the injected agents into the epidural space and 
to adjacent nerve roots may influence the reliability and selectivity of diagnostic SNRBs.
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Chapter 2
DIAGNOSIS IN PATIENTS WITH CHRONIC RADIATING LOW BACK
PAIN WITHOUT OVERT FOCAL NEUROLOGICAL DEFICITS: 
WHAT IS THE VALUE OF SEGMENTAL NERVE ROOT BLOCKS?
Therapy 2005; 2: 4: 577-585
André P. Wolff 1,2, Gerbrand J. Groen 2, Oliver H.G. Wilder-Smith 1
1 Pain Centre, Institute for Anesthesiology, Radboud University Nijmegen Medical Centre
2 Division of Perioperative Medicine and Emergency Care, Department of Anesthesiology,
University Medical Centre Utrecht
2.1
Summary
The purpose of this paper is to discuss the value of spinal segmental nerve root blocks
in establishing diagnosis in chronic low back pain patients with pain radiating to the leg 
without overt focal neurological deficits. These patients represent a large population.
Establishing diagnosis is often problematic and the effectiveness of presently available 
therapies is low. Indication, character of radiating pain, pain diagnosis, factors influencing 
segmental nerve blocks, reliability of segmental nerve root blocks in diagnosing pain,
recently performed studies on the reproducibility of segmental nerve block effects and 
considerations with respect to ‘segmental  pain’ will be discussed herein.
2.2
Introduction
Segmental Nerve Root Blocks (SNRBs) are applied for diagnostic purposes in patients
with radiating pain to determinate the pain-conducting segmental spinal level 1-7. SNRBs have
been applied in patients with chronic lower back pain radiating to the leg (CLBP-r) to select
those eligible for a radiofrequency procedure of the dorsal root ganglion 7,8 (RF-DRG).
A positive SNRB can further be used to establish the indication for spinal segmental nerve
injection therapy 9-14. Huston and Slipman 14 and Gajraj 15 have reported that SNRBs are 
valuable in the assessment of sciatica, but warn of the mainly retrospective nature and 
procedural limitations of the studies describing the predictive value. High sensitivity and
specificity are attributed to SNRBs when used to predict surgical outcomes in patients with
specific radicular syndromes. These patients suffer from nerve compression with secondary
neurological deficits as result of a lumbar herniated disc or spinal stenosis 3-6,14,16-19 . Hogan,
in contrast, postulates that no role has been demonstrated for SNRBs in evaluating patients
for neuroablative procedures 20.
Radiating pain
CLBP-r patients may exhibit pain following a spinal segmental pattern or a non-
segmental pattern, whereby a segmental pattern is defined as being concordant to the 
innervation area of a spinal (segmental) nerve. Non-segmental radiating pain may be 
referred, caused by local sources in the posture and motor apparatus of the back 21, but may
also be related to structures outside the back. Furthermore, radiating pain can be related 
to a neuropathy of a peripheral nerve.
When pain is felt in one neuraxial segment we distinguish between pain with a 
specified, diagnosable, cause and pain in which no certain cause can be established. When 
a patho-anatomic cause, related to a spinal segmental nerve, nerve root or dorsal root 
ganglion is ascertained, and pain follows the innervation area of a spinal nerve (i.e.,
dermatome, myotome or sclerotome), it is defined as radicular pain. When radicular pain is
accompanied by sensory changes in the corresponding dermatome, by decrease in motor
function in the corresponding myotome, by positive spinal nerve stress tests and decreased
tendonreflexes corresponding to the symptomatic level, it is defined as radiculopathy.
We should be aware that a substantial part of CLBP-r pain patients does not conform
to the diagnostic criteria for radiculopathy. In many of these patients obvious causal 
pathology related to the spinal nerve suspected to be involved cannot be demonstrated with
the presently available diagnostic tools. Nevertheless, patients may experience pain that 
follows a segmental or a segment-like pattern. To differentiate between radicular pain and
radiculopathy, we propose to define this type of radiating pain, in which a specified cause
cannot (yet?) be found, as segmental pain. A classification with respect to different types of
pain radiating into the leg is displayed in table 1.
2.3
Pain diagnosis
Radiological examinations, such as plain radiography, myelography, discography,
CT and MRI have a low specificity with respect to establishing the pain cause or source of
the pain. For example, a herniated disc may be the cause, but the compressed and excitated
dorsal root ganglion is the source 7,22-25. Potential pain generating conditions, such as a 
herniated disc, spinal stenosis and epidural fibrosis can be present in symptom free patients,
and vice versa. Thus, the quest for a patho-anatomic cause for CLBP-r remains a challenge.
In this search, spinal endoscopy is a promising diagnostic and potential therapeutic tool,
which can be performed in addition to (and in the future perhaps as replacement of) presently
available radiological and clinical neurological examinations. This technique has received
more attention recently and is of interest, due to its ability to aid in diagnosing pathology 
in the epidural space that cannot, or cannot yet be demonstrated in another fashion, such 
as MRI or CT. Using spinal endoscopy, abnormalities such as spinal nerve inflammation, can
be visualized that may compromise or threaten radicular nerves 26-29.
Neuro-inflammatory and neuro-immunological processes in the spinal cord, spinal
nerve root, dorsal root ganglion or spinal nerve 30-33 may explain the presence of radicular
pain that cannot at present be diagnosed by radiological examination. These processes,
as well the presence of chronic pain itself, may result in altered nervous system function 
(i.e., neuroplasticity). Such neuroplastic mechanisms 34-37 can lead to pain that persists after 
an initial nociceptive triggering process or event, which may not be present or detectable 
any more later on. The interpretation of this type of pain can be difficult because other 
pain sources that can generate radiating pain as well may be present concurrently:
e.g., spondylolisthesis, disorders of facet joints, intervertebral disc(s), sacroiliac joint 
or tendomyogenic structures. Olmarker 30 demonstrated that the intervertebral disc is a 
potential source of biochemical substances that may directly and indirectly lead to 
excitation of dorsal root ganglion cells (PLA2 and TNF-α). This complex picture is further
complicated if pain originates from regions outside the back, the peripheral nervous system
or the central nervous system. Finally, multisegmental innervation of the spine and 
dermatomal overlap 38,39, presence of neuronal networks in the spine 21,40, and influence of
psychogenic and behaviour-related factors can all coalesce to make the clinical diagnosis of
CLBP-r extremely difficult. Thus, pain originating from the spine or related structures will be
referred multisegmentally as a result of its multisegmental innervation 21,40. This pain is 
defined as pseudo-radicular pain and is generally felt in parts of more than one dermatome.
It can mimic segmental radiating pain, despite having no actual segmental origin (table 1).
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Table 1  Radiating pain
Pain distribution Neurological Patho-anatomical
in neuraxis segment deficits substrate
Segmental
Radiculopathy + + +
Radicular pain + - + 
Segmental pain + - -
Non-segmental
Referred pain - - + (or ?)
In case of nerve root compression, the presence of radiating pain with a dermatomal
pattern in the leg (i.e., radicular pain) seems to be one of the most significant diagnostic 
features. The sensitivity of this diagnostic symptom is reported as lying between 90% and
99% 41,42. However, not one single physical test or examination appears to have an equally
high sensitivity and specificity for radiculopathy 43. In summary, the diagnostic accuracy of
history taking and physical examination still remains unclear in the diagnosis of low back
pain with radiation to the leg.
Factors influencing segmental nerve root blocks
The diagnostic use of SNRBs is based on the assumption that SNRBs can identify 
segmental pain and its spinal level by using significant pain reduction as an end-point.
However, so far there is no gold standard against which the SNRB result can be measured.
Therefore, there is a strong need to develop measures to confirm the effectiveness of SNRBs.
Changes in sensory and motor function could be a useful tool to clinically document the
reliability of SNRBs. Despite the fact that SNRBs have been used for many years in back pain
diagnostics, only few studies systematically have described the clinical effects of SNRBs.
In table 2 we present methods, which could be helpful in testing spinal segmental nerve 
function in humans. Table 3 shows the most commonly applied tests for quantifying 
alterations in spinal nerve function.
Table 2  Techniques used to test human spinal nerve function
Nerve stimulation mechanical
electrical
Nerve block conduction block with local anaesthetic agent
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Table 3  Most commonly used tests to quantify alterations in nerve function
Function Examination
Sensory/Pain QST (Quantitative electrical; gradual, continuous
Sensory Testing) mechanical; gradual, continuous








Motor muscle force in myotome
spinal reflexes
EMG
Sympathetic skin infrared thermography 
skin impedance (galvanic reflexes)
skin temperature
Furthermore, the technique used to identify the spinal nerve root, the dorsal root 
ganglion or the spinal nerve must be reliable and reproducible. The needle should be intro-
duced and inserted to the upper, dorsal part of the intervertebral foramen (just intra- or
extraforaminally) and should be documented radiologically. Use of imaging guidance via
fluoroscopy or CT is strongly recommended. The spinal nerve, spinal nerve root or dorsal root
ganglion may be mechanically or electrically stimulated via the tip of the needle, evoking
paraesthesias in the corresponding dermatome and provoking muscle contractions in the
corresponding myotome. A low volume of radio contrast dye (0,2-0,5 ml) should also be
injected to visualize its spread around the target neural structure. In this way the target 
neural structure is made visible and it allows assessment of unwanted spread of the injected
solution. The spread should be limited to the target structure. It is important that 
neural structures lying at spinal segmental levels above or below the target level should be
unaffected. To prevent unintended non-targeted spread of the injected agent to adjacent 
neural tissues, a low volume should be injected extradurally (sometimes this is described 
as peridurally), either in- or outside the intervertebral foramen.
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Figure 1 Representation of spinal nervous structures 
and needle placement in the upper part of
the intervertebral foramen. DRG, dorsal root 
ganglion; svn, sinu-vertebral nerve.
Theoretically, anaesthetizing the mixed spinal nerve extraforaminally should block
afferent signals coming from peripheral sites distal to the injection and thus prevent 
centripetal conduction (figure 1). In an intraforaminal block chances are higher to block the
so-called sinu-vertebral nerves as well. These nerves conduct afferent signals from the spine
itself, e.g. from neighboring intervertebral discs, anterior and posterior ligaments of the spine,
and ventral dura 21,40. Although the dorsal ramus, originating just outside the intervertebral
foramen, may remain out of reach of an intraforaminal block, it should be noted that the
sensory fibers from the dorsal nerve pass through the dorsal root ganglion, and, consequently,
are blocked as well. This nerve branch innervates local muscles in the back and the neigh-
boring facet joints. Furthermore, it has been reported that pain generated proximal to the
nerve block may be relieved by a conduction block performed distal to the exciting locus. In
this way, pain related to proximal spinal nerve root excitation and experienced in the leg and
the back 44,45 is affected by a distant block.
The concept of “controlled blocks” for zygapophysial joint blocks 46 to increase 
reliability and improve interpretation may also be applied for SNRBs: blocks are performed
on two different occasions, with a short and a long acting local anaesthetic agent in equipo-
tent dosage. The duration of pain reduction should correspond with the duration of
action of the local anaesthetic agent used. It may be expected that not only duration of pain
reduction, but also duration of other concomitant changes, e.g. in sensory and motor 
function, should be concordant to the duration of effect of the local anaesthetic agent used.
However, in our experience, this is not always the case. To further increase reliability,
we should also take into account the presence of multisegmental innervation 21,40. Thus we 
would suggest that SNRBs should be performed at least at 2 or 3 spinal levels. These double 
controlled blocks with long and short acting local anaesthetics have been advocated as gold
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standard 46, however, in view of the discussion above with regard to single SNRBs, this is 
hardly likely. Even controlled blocks do not distinguish between source and cause of the pain.
When the local anaesthetic reaches the target neural structures, it has to diffuse into
these structures before it can exhibit its blocking property. Local effects may be affected 
by factors such as the physical and chemical properties of the local anaesthetic agent.
Furthermore, size and position of the dorsal root ganglia may vary in relation to the inter-
vertebral foramen 47-53. There is a large variation in anatomic positions of dorsal root ganglia.
Three positions are possible: outside the foramen, inside its aperture, and actually within the
spinal canal (figure 2). In this context, the use of radio contrast dye and electrostimulation
may be helpful to raise insight into the variability of the dorsal root ganglia topography.
Furthermore, spinal nerve roots and ganglia have an internal topographic organization 
regarding nervous and non-nervous cells 49 So far, it is unknown if there is a relationship 
between electrostimulation and the intraganglionic topographic organization. Therefore,
the effects of the local anaesthetic within the innervation area of a spinal nerve can be expec-
ted to vary, dependent upon its penetration into in the dorsal root ganglion and spinal nerve.
Figure 2 Variation in anatomic positions of the dorsal
root ganglia (redrawn and adapted from Hasue
et al 1989) with regard to the intervertebral
foramen. At the left the location of the dorsal
root ganglion (DRG) with respect to the inter-
verebral foramen is depicted. The percentages
on the right side represent the incidence of the
indicated position at spinal level L5 or S1.
Reliability of segmental nerve root blocks
Pain patterns, pain reduction and concomitant changes in sensation and muscle force
by SNRB, should be clearly associated with the blocked spinal segmental nerve. To date,
no data are available with respect to the reproducibility of sensory effects, pain reduction,
and motor effects by SNRB. The same holds true for elicited paraesthesias.
SNRBs should be sensitive and specific. North et al 45 reported a high sensitivity, but 
a low specificity for SNRBs in the context of sciatica patients. In these patients blocks,
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performed at spinal level L5 and S1, were compared with sciatic nerve blocks, consecutive
blocks of the medial branch of the dorsal ramus (i.e., supplying the facet joints) and 
subcutaneous injections with local anaesthetics. Surprisingly, they found that the two blocks
performed far from the affected spinal nerves also resulted in significant pain reduction 
in a substantial number of patients compared to SNRBs of the affected spinal nerve.
Subcutaneous injections did not lead to pain reduction. The authors argued that negative
blocks may have some predictive value, but that isolated, positive, i.e. pain reducing, blocks
are to be considered non-specific. All included patients had positive diagnostic imaging 
findings of ongoing nerve root compression or a positive history of root compression, which
had been identified surgically.
In CLBP-r patients, who have no detectable and specific underlying diagnosis for their
radicular pain, it is impossible to generate data on sensitivity and specificity with respect to
SNRBs. However, an alternative or better tool than SNRB to identify segmental pain is not
available at this moment.
The lack of a diagnostic gold standard in patients with chronic, non-specifiable,
radiating pain emphasizes the need to develop other methods to monitor the quality and
reliability of SNRBs, by systematically documenting sensory and motor function 39,54,55.
Such methods could include: 1) paraesthesias elicited by electrostimulation, 2) changes in
sensory function, and changes in muscle force. Findings resulting from monitoring these
signs should correspond to the blocked spinal level. The method should be consistent and
reproducible. Until recently, no studies had been performed to answer these questions.
However, with respect to the large population of CLBP-r patients without overt focal 
neurological deficits and with respect to the frequent need for diagnosis and treatment 
of these patients, this is extremely relevant.
Studies on the consistency of SNRB effects
Interesting findings of a series of studies to the relationship between segmental 
pain in the leg, pain reduction, and changes in sensory and motor function after SNRBs in
CRLB-r patients without overt focal neurological deficits 39,54,55 will be discussed here.
The first finding is that the incidence, location and extent of skin areas with hypo-
aesthesia for pin prick after SNRB are very variable. These results can be seen in a so-called
density map of hypoaesthetic effects for pinprick after SNRB (chapter 3). The extent of the
total skin area where hypoaesthesia is found in this series appears to be extremely large.
Of notice is the fact that in some patients no hypoaesthesia develops at all, although all nerve
blocks were technically adequate. It seems that patterns of pain radiation and hypoaesthesia,
which mostly exceed the boundaries of the standard dermatomes can be better understood
if overlap by neighboring dermatomes is taken into account in the representation of der-
matomes (chapter 3). The resulting “adapted” dermatomes are then seen to be twice as large
as in standard dermatomal maps. Using the map with “adapted” dermatomes, sensory 
clinical SNRB effects occur more often within the dermatomal boundaries. In contrast,
the variability of paraesthesias elicited by electrostimulation is much lower, being mainly
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experienced in the central part of the standard dermatome. The reproducibility of para-
esthesias elicited with electrostimulation via the tip of the needle appears to be high: 80% of
experienced paraesthesias are found to be present within the boundaries of the corresponding
standard dermatomes and in 98% paraesthesias are found within the boundaries of the 
corresponding, “adapted”, dermatome. Nevertheless, the relation with pain remains poor:
when pain is experienced in a specific “adapted” dermatome, only in one third of the cases
concurrent pain reduction, paraesthesias and hypoaesthesia are present in this dermatome.
When the sensory function is tested with pinprick before SNRB in CLBP-r patients
without overt focal neurological deficits, it is found that in the majority of the cases a 
variable pre block hypoaesthesia is present 54 (chapter 4). This alteration in sensory function
may change in time and location. Although a large variability in extent of post block 
hypoaesthesia is found, the changes with block are non-significant compared to pre block
situation. The presence of the pre block alterations in sensory function may be the result of
neuroplastic effects due to the chronicity of pain in these patients.
When the SNRB effects on motor function are examined 55 (chapter 5), it appears 
that average muscle force within the corresponding myotome decreases with block. However,
the muscle force in the corresponding myotome increases if pain is reduced by the nerve
block. This finding can be interpreted as follows: in patients with chronic pain in the leg,
pain has an inhibitory effect on the muscle force 56 (so-called diffuse noxious inhibitory 
control or DNIC, a phenomenon also attributed to neuroplasticity). After pain reduction,
inhibition is ceased, which normalizes muscle force.
These observational studies demonstrate that long lasting back pain with segmental
radiation to the leg, even when specific causes have not been found, induces neuroplastic
changes in both the sensory and motor system. It is possible that the large variability in 
sensory effects with SNRB is also related to these neuroplastic changes. However, the role of
multisegmental innervation should not be forgotten in this context. It should be emphasized
that the segmental changes related to sensory and motor function are poorly reproducible 
in CLBP-r patients. Only the elicitation of paraesthesias with electrostimulation is reliably
reproducible in a dermatomal fashion. At present this combination of clinical signs present
after SNRBs is not useful to assess the quality of SNRBs.
Does segmental pain exist?
As discussed above, attempts to select only those patients that have segmental pain,
from the large population of CLBP-r patients, have remained futile. Even assessing the effec-
tiveness of SNRB by measuring subsequent successful treatment outcome as endpoint did
not resolve the problem. The diagnostic value of SNRBs as selection tool for successive 
segmental invasive pain treatment could also not be confirmed in a recent study by Geurts 
et al. 8 In a prospective, randomized and placebo controlled study they demonstrated that
radiofrequency treatment of lumbosacral dorsal root ganglia in patients with radicular pain,
selected with SNRBs, were not effective. However, one should add that in that study 
controlled, double blocks have not been used for patient selection. Besides the lack of
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treatment effectiveness itself, this could also be attributed to SNRB-bound properties, e.g.,
low selectivity of SNRBs or absence of applying double controlled SNRBs, or to wrong con-
cepts or hypotheses with respect to the phenomenon of segmental pain. Thus, “segmental
pain” as clinical concept lacks experimental evidence for its existence when no specific cause
can be demonstrated. It appears that, with respect to underlying mechanisms in chronic 
radiating pain, we will have to find other conceptual frameworks. A possible alternative 
framework would involve the afore-mentioned mechanism of neuroplasticity. With the 
presently available diagnostic tools we cannot clearly demonstrate, or exclude, processes 
such as (neuro-) inflammation or persistent neuroplasticity. It should be noted that 
neuroplasticity can be segmental, e.g. sensitisation of dorsal root ganglion neurones and 
glial cells 35. However, the lack of consistent segmental effects of SNRB makes it unlikely that
it will aid in the diagnosis of this type of problem, either.
In future, studies of pain related neuroplastic changes in sensorimotor systems may
provide us with more insights in underlying pain mechanisms. It is of eminent importance
that we obtain a better understanding of the mechanism involved in the development of
pain, of the processes facilitating the chronification of pain, and of its impact on systems
involved. If segmental effects are related to pain, then diagnosis and treatment should take into
account that the nerve cells involved are connected both to peripheral (sensory and motor
function) and central neural structures higher in the neuraxis. Increasing numbers of studies
performed in the last few years have demonstrated that pain, chronicity, neuroplasticity,
cerebral functions, emotions, cognitions and behaviour are all strongly related to each other.
Longer lasting back pain with non-specifiable “segmental” pain should be viewed as being a
part of a more extended and complex system that demonstrates functional plasticity. It would
seem that our conceptual frameworks with respect to the concept of “segmental” pain and
with regard to diagnostic “segmental” nerve blocks as main tool, have to be reconsidered.
Further studies should demonstrate if this assumption is correct or not.
We have to keep in mind that the diagnosis ‘”segmental pain” is a constantly evoking
concept. Our diagnoses are dependent on our diagnostic tools, and these diagnostic tools
should provide us with a better insight in underlying mechanisms. Therefore, an important
future goal in the context of CLBP-r patients would be to develop more sophisticated 
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DIAGNOSTIC LUMBOSACRAL SEGMENTAL 
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3.1
Summary
Introduction. Selective spinal nerve infiltration blocks are used in patients with 
chronic low back pain radiating into the leg. Generally, a segmental nerve block is conside-
red successful if the pain is reduced substantially. Hypoaesthesia and elicited paraesthesias
coinciding with the presumed segmental level are used as controls. The interpretation depends
on a standard dermatomal map. However, it is not clear if this interpretation is reliable
enough, because standard dermatomal maps do not show the overlap of neighboring 
dermatomes. The goal of the present study is to establish if dissimilarities exist between 
areas of hypoaesthesia, spontaneous pain reported by the patient, pain reduction by local 
anaesthetics and paraesthesias elicited by sensory electrostimulation. A secondary goal is to
determine to what extent the interpretation is improved when the overlaps of neighboring
dermatomes are taken into account.
Methods. Patients suffering from chronic low back pain with radiating into the leg
underwent lumbosacral segmental nerve root blocks at subsequent levels on separate days.
Lidocaine (2%, 0.5 mL) mixed with radiopaque fluid (0.25 mL) was injected after verifying
the target location using sensory and motor electrostimulation. Sensory changes (pinprick
method), paraesthesias (reported by the patient), and pain reduction (Numeric Rating Scale)
were reported. Hypoaesthesia and paraesthesias were registered in a standard dermatomal
map and in an adapted map in which included overlap of neighboring dermatomes.
The relationships between spinal level of injection, extent of hypoaesthesia, location of
paraesthesias, and corresponding dermatome were assessed quantitatively. Comparison 
of the results between both dermatomal maps was done by paired t-tests.
Results. After inclusion, data were processed for 40 segmental nerve blocks (L2-S1)
performed in 29 patients. Pain reduction was achieved in 43%. Hypoaesthetic areas showed
a large variability in size and location, also in comparison to paraesthesias. Mean hypo-
aesthetic area amounted 2.7 ± 1.4 (± SD: range, 0 to 6; standard map) and 3.6 ± 1.8 (0 to 6;
adapted map; P < .001) dermatomes. In these cases, hypoaesthesia in the corresponding 
dermatome was found in 80% (standard map) and 88% of the cases (adapted map, not 
significant). Paraesthesias occurring in the corresponding dermatome were found in 80%
(standard map) compared with 98% (adapted map, P < .001). In 85% (standard map) and
88% (adapted map), spontaneous pain was present in the dermatome corresponding to 
the level of local anaesthetic injection. In 55% (standard map) versus 75% (adapted map,
P < .005), a combination of spontaneous pain, hypoaesthesia, and paraesthesias was found
in the corresponding dermatome.
Conclusions. Hypoaesthetic areas determined after lumbosacral segmental nerve
blocks show a large variability in size and location compared to elicited paraesthesias.
Confirmation of an adequately performed segmental nerve block, determined by coexisten-
ce of hypoaesthesia, elicited paraesthesias and pain in the presumed dermatome, is more 
reliable when the overlap of neighboring dermatomes is taken into account.
3.2
Introduction
Selective segmental nerve blocks are applied for diagnostic purposes in patients with
chronic pain to differentiate the segmental level of pain 1-5. If the pain lasts more than 6 months
without improvement despite conservative treatment, and if a selective segmental block has
led to temporary pain relief, there may be an indication for invasive symptomatic pain 
treatment 1. To assess the quality of a diagnostic segmental block, the presence and extent 
of temporary motor deficit, dermatomal hypoaesthesia, and elicited paraesthesias are 
useful criteria.
Location and size of hypoaesthetic regions and intensity of paraesthesias are general-
ly evaluated by using a standard dermatomal map. In the past, different attempts have been
made to develop a human dermatomal map. Maps were designed based on the location 
of skin eruptions in herpes zoster 6, innervation territories of peripheral branches of lum-
bosacral and brachial plexuses by meticulous anatomical dissection of 1 human 7, and by 
experimental animal work on monkeys 8. Sherrington 8 determined dermatomal areas by using
the isolation method and checking the areas of remaining sensibility. Sherrington used the
"remaining sensibility method" or "isolation method" in monkeys, by cutting a continuous
number of dorsal roots and leaving intact the most middle root. In this way, he created for
nearly all spinal nerves areas with intact sensibility surrounded by areas in which sensibility
was absent. Thus, he proved an overlap in sensory nerve supply by consecutive nerve roots and
showed that most cutaneous loci were innervated by 2 or 3 dorsal roots. Larger dermatomal
areas were found with considerable overlap between neighboring dermatomes. Keegan and
Garrett 9 used local anaesthesia of the dorsal root ganglia in healthy subjects. Hansen and
Schliack 10 made use of the above-mentioned studies and synthesized the data with personal
clinical observations into a renewed human dermatomal map. Their map was again modified
by Buckhöj (an artist) and is currently used in many pain clinics and anaesthesia practices.
The maps of the dermatomes in humans worked out by different methods are not concor-
dant in all respects, but the main patterns are identical 11.
Diagnostic segmental blocks performed at the same level do not always produce 
equal dermal extension of sensory changes 12 and may provide false-positive results 13. North
et al. 13 compared the temporary pain-relieving effects of lumbosacral nerve root blocks,
sciatic nerve blocks, medial branch posterior primary ramus blocks, and subcutaneous 
injections in patients with sciatica and diagnosed root entrapment. The first 3 blocks 
produced temporary relief in the majority of patients despite the fact that they were distal to
the entrapped nerve. The study hypothesis was confirmed that false-positive results are 
common and specificity is low. Much of the exact mechanism of diagnostic segmental 
nerve blocks still needs to be elucidated.
In the present study the extension of sensory changes after single segmental 
lumbosacral nerve blocks was assessed by the pinprick method and fitted in a standard 
dermatomal map (Buckhöj; Astra-Zeneca, Sødertälje, Sweden; Figs 1A and 2A) frequently
used in investigations in local and regional anaesthesia. Sherrington 8 and Foerster 14 showed
that neighboring dermatomes overlap to a large extent. This means that the full extent of
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each dermatome is larger than depicted in the vast majority of complete dermatomal maps.
Foerster 14 defined the total extent of a dermatome as “one dermatome to which both half
neighboring dermatomes were added”. However, in Foerster’s dermatomal map, not all 
dermatomes are presented as a continuum from proximal to the periphery. Therefore,
Keegan and Garrett 9 proposed a dermatomal chart representing dermatomes extending 
without interruption from the dorsal midline to their termination. However, Keegan and
Garrett’s chart represents only the core of the dermatomes, described as “areas of primary
hyposensitivity”. As a result, we modified the frequently used standard map of Buckhöj 
by adding to the original dermatome both halves of the 2 neighboring dermatomes.
Thus, larger dermatomes were obtained (adapted map; see Figs 1B and 2B). The findings
were quantitatively fitted in both maps and compared with each other.
Although spinal segmental test blocks are performed to obtain more insight into pain
patterns, the questions in this study were limited to the following issues: (1) How often does
a single segmental nerve block lead to hypoaesthesia in the corresponding dermatome? (2)
How often does electrical nerve stimulation of a single segmental nerve elicit paraesthesias in
the corresponding dermatome? (3) How often do areas of spontaneous pain, hypoaesthesia,
and elicited paraesthesia coincide within the corresponding dermatome? The results will 
be compared between the standard and adapted dermatomal map.
Patients and Methods
Patients suffering from unilateral chronic low back pain radiating to the leg, in which
noninvasive therapy was excluded, were referred for symptomatic invasive pain treatment.
All patients were examined extensively, including by computed tomography (CT), magnetic
resonance imaging (MRI), and electromyograph (EMG), and diagnosed as “radicular 
syndrome without neurological deficit” by a neurologist or an orthopedic surgeon. Patients
were recruited in accordance with the rules of the Declaration of Helsinki and the study was
approved by the Hospital Ethics Committee. Written informed consent was obtained from
each patient. All patiënts were over 18 years of age.
Exclusion criteria were the following: availability of noninvasive therapy, known 
hypersensitivity to amino-amide-type local anaesthestics or iodide, presence of coagulo- 
pathy, or mental disorders. In the study period, 38 consecutive patients with radiating 
pain in the lower limbs were considered for diagnostic lumbosacral segmental nerve blocks.
After obtaining written, informed consent, 29 patients were enrolled the study. They 
were scheduled for 3 test blocks with local anaesthetics - 1 block at the segmental nerve 
corresponding with the most painful dermatome, and the remaining 2 at the super- and 
subjacent levels. Finally, during the study period, 29 patients underwent 42 diagnostic 
segmental nerve blocks at lumbosacral levels according to the experimental protocol.
The blocks were performed by three anesthesiologists specialized in invasive 
pain treatment. A research fellow, unfamiliar with the exact level of the executed block,
performed assessment of the blocks.
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Technique
The patient was positioned prone. Fluoroscopy was executed in an antero-posterior
and lateral direction. Under fluoroscopic guidance, the insertion site of the needle was 
marked on the skin by a skin marker. After subcutaneous injection with 1 mL of lidocaine
1.5%, a 10-cm isolated needle was inserted into the intervertebral foramen (23-gauge,
Top-XE, Top Corp, Tokyo, Japan).
To confirm the position of the needle, an electrical current generated by a radio 
frequency pulse and lesion generator system (model RFG-3B; Radionics, Burlington, MA,
USA) was applied, stimulating the segmental nerve. Paraesthesias were evoked by stimulation
with a frequency of 50 Hz and muscular contractions by stimulating at 2 Hz. The 
paraesthesias elicited in the patient were registered by the anesthesiologist in an empty 
dermatomal map. The anesthesiologist recorded the locations of these sensations as 
expressed by the patient as well as the presence of muscular contractions manifest during
electrical stimulation. Thereafter, 0.3 mL contrast medium (Omnipaque Nycomed Ireland,
LTD, Cork, Ireland) was injected through the needle to visualize the segmental nerve.
Radiographs were taken for documentation. Then a mixture of 0.5 mL lidocaine 2% 
(Astra Pain Control AB, Södertälje Sweden) and 0.25 mL of contrast dye was injected. In case
of epidural or abnormal spread the data were excluded from further analysis. The “blind”
investigator examined the patients twice: 30 min before and between 15 to 30 minutes after
the injection. Sensory tests were performed in the affected limb from distal to proximal in
annular shapes at 10-cm distances by pinprick (hypo, 825044A, 27-gauge, MPL Technologies
Inc, Franklinpark, IL, USA). The other limb was used as a reference.
The areas with sensory changes were fitted in the standard and the adapted derma-
tomal map (figure 1 and 2).
Figure 1 Standard dermatomal map (a) 
vs adapted dermatomal  map (b), anterior.
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Figure 2 Standard dermatomal map (a)
vs adapted dermatomal map
(b), posterior.
The dermatomal map was provided with a grid with a resolution of 1 mm2 to quan-
tify the surface of the hypoaesthetic areas. Hypoaesthetic areas were marked. The number 
of marked squares per dermatome, as well as the total number of marked squares were 
counted. Thus, the relative sizes of hypoaesthetic areas within affected dermatomes in 
comparison to the total hypoaesthetic areas were calculated. This was done for both 
standard and adapted maps. With the standard map, each affected locus in a hypoaesthestic
area lies in only 1 dermatome. These dermatomes are only neighboring. Using the adapted
map, each affected locus is, by definition, lying in more than 1 dermatome because the 
larger dermatomes on the adapted map do overlap. Therefore, the mean hypoaesthetic area
will be larger using the adapted map. For example, when a small coin-sized area is affected 
at the lateral side of the knee with a total surface of "X", it can only be counted once in 
dermatome L5 in the standard map. In the adapted map, the affected area is found within 
dermatome L5, but also in L4 (see Figs 1 or 3). When we calculate the total surface of the
hypoaesthetic area using the standard map we only can count "X", but using the adapted
map in this case we can count "2X". To determine which areas were hypoaesthetic in the
majority of patients, intensity maps were produced from superimposed data of all cases.
The following data were processed: the dermatome(s) in which the patient experien-
ced the pain, the pain score before and after the segmental nerve block (on a 10-point
Numeric Rating Scale (NRS), 0 = no pain, 10 = unbearable pain), the spinal level of the 
blocked nerve, the voltages at which paraesthesias and muscle contractions were perceived
during electrical stimulation (mean ± SD), and the dermal projection of paraesthesias.
A decrease of at least 2 points on the NRS was considered as clinically significant.
To compare the effects related to the level of spinal nerve infiltration, hypoaesthesia,
and paraesthesias between standard and the adapted dermatomal maps, the paired t-test was
used with a confidence interval of 95%.
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Figure 3 Hypoaesthetic area, developed in a
case after a segmental nerve block of
S1, projected on a standard (a) and
on a adapted dermatomal maps (b,c).
Results
Forty-two segmental nerve blocks were performed in 29 patients. Data of 2 block
procedures were excluded from further analysis because of epidural spread. An L2 
nerve block was performed in 6 cases, an L3 in 1, an L4 in 8, an L5 in 14, and an S1 in 11
cases. In all cases, the number of the vertebrae from C1 to the treated level was normal.
For demographic data, see Table 1.





age (sd, spread) 49.3 (11.0, 29-77)
blocks 40 
In figure 3, a hypoaesthetic area, developed in a case after a segmental nerve block of
L4, is presented in a standard map (3A) and in adapted dermatomal maps (3B and 3C).
Superimposition of hypoaesthetic areas per level of segmental nerve block shows a large
overlap in all cases, as shown for levels L5 and S1 in intensity maps (Figs. 4 and 5).
Hypoaesthesia locations with the highest intensity are found at the anterior thigh (L2, 30%),
at the anterolateral side of the knee (L4, 40%), at the lateral caudal half of the lower leg 
and lateral ankle (L5, 80%) and at the dorsolateral thigh, lateral ankle, and lateral side of
the foot (S1, 60%).
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Figure 4 Intensity map of L5 areas of hypoaesthesia (grey tones in
right legs) and paraesthesias (black dots in left legs; grey
area represents total area of hypoaesthesia) in 15 patients.
Areas of hypoaesthesia and paraesthesia of all patients have
been superimposed. The grey tones correspond with the
intensity scale that describes the percentage of patients in
which the areas overlapped each other.The darkest areas
represent sites that were found hypoaesthetic in the 
largest number of patients. For paraesthesia it is depicted
as more black dots at a certain spot.
Figure 5 Intensity map of S1 areas of hypoaesthesia (grey tones in
right legs) and paraesthesias (black dots in left legs; grey
area represents total area of hypoaesthesia) in 11 patients.
Areas of hypoaesthesia and paraesthesia of all patients have
been superimposed. The grey tones correspond with the
intensity scale that describes the percentage of patients in
which the areas overlapped each other.The darkest areas
represent sites that were found hypoaesthetic in the 
largest number of patients. For paraesthesia it is depicted
as more black dots at a certain spot.
Elicited paraesthesias are found in the anterior side of the upper leg, knee and upper
part of the lower leg (L4), over the buttock along the dorsal side of the thigh and lateral side
of the lower leg to the great toe (L5, Fig. 4), and from the buttock over the dorsal side of
upper and lower leg to the lateral side of the foot to the fifth digit (S1, Fig. 5).
Comparisons were made between the presence of spontaneous pain, hypoaesthesia,
paraesthesia and pain reduction in corresponding dermatomes in standard and adapted 
dermatomal maps (Fig. 6). In all but one (i.e. frequency of hypoaesthetic area) the frequency
of signs and symptoms located in the corresponding dermatome is significantly higher in
the adapted dermatomal map.
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Figure 6 Relationships between frequency of presence of spontaneous pain, elicited paraesthesias (par), hypoaesthesia
(hyp), decrease in pain (dNRS) in corresponding dermatomes of standard (blank) vs adapted (dashed) 
dermatomal maps in 40 cases undergoing lumbosacral segmental nerve blocks. * p<0.05.
After single segmental nerve blocks, hypoaesthesia was found in 34 cases (85%),
but was not detected in 6 cases (15%). The hypoaesthetic surface areas as recorded on the
dermatomal maps (both standard and adapted) varied from 0 to 1,244 mm2 (mean ± SD,
537 ± 357 mm2; Fig. 7). In 40 cases, areas of hypoaesthesia were recorded within the boun-
daries of a total of 106 (standard map) and 145 dermatomes (adapted map). Hypoaesthetic
areas extended over 2.7 ± 1.4 dermatomes (mean ± SD; range, 0 to 6; standard map) and 
3.6 ± 1.8 dermatomes (mean ± SD; range 0 to 6; adapted map; P < 0.001, paired t-test).
Figure 7 The hypoaesthetic surface areas per segmental nerve block (L2 6 cases, L3 1 case, L4 8 cases, L5 14 cases 
and S1 11 cases) as recorded on the dermatomal maps, both standard and adapted, depicted in mm2.
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Hypoaesthesia occurred in the corresponding dermatome in 32 cases (standard 
map) and 35 cases (adapted map; not significant (NS), paired t-test). The mean hypoaesthetic
surface area in the corresponding dermatome (as percentage of the mean total hypoaesthetic
area) was 26% (standard map) versus 52% (adapted map; P < 0.01, paired t-test). Using 
the standard map, at least 50% of the total hypoaesthetic area was found within the 
corresponding dermatome in only 6 cases (15%), but in 23 cases (58%; P < 0.001, paired 
t-test) for the adapted map.
The mean measured voltage necessary to elicit paraesthesias was 0.8 ± 0.6 V, range 
0.1 to 2.0 V. Muscle contractions were elicited at a mean voltage of 1.4 ± 1.1 V, range, 0.15 
to 4.0 V. After electrical stimulation, in 32 cases (80%, standard map) versus 39 cases 
(98%, adapted map; P < .01, paired t-test) paraesthesias were experienced in dermatomes
corresponding to the level of the segmental nerve block. In the remainder of cases,
paraesthesias were perceived in dermatomes not corresponding to the level of the stimulated
segmental nerve. Areas with paraesthesias were generally of limited size and showed a more
bandlike pattern in comparison with hypoaesthetic areas. In 26 cases (65%, standard map)
versus 34 cases (85%, adapted map; P < 0.005, paired t-test) hypoaesthesia and paraesthesias
were recorded in the corresponding dermatome.
In most cases, spontaneous pain was located in an area exceeding the boundaries of
at least 2 dermatomes with a mean of 2.4 ± 1.3 dermatomes (mean ± SD, range 1 to 6; total
93; standard map) versus 3.4 ± 1 dermatomes (mean ± SD, range, 2 to 6; total 131; adapted
map; P < 0.001, paired t-test). Using the standard dermatomal map, pain was present in only
1 dermatome in 11 cases. Using the adapted map, in 5 cases pain was present in just 2 
dermatomes. In 34 and 35 cases, pain was present in the dermatome corresponding to the 
treated spinal nerve. In 17 cases (43%, both maps) pain was reduced significantly, of
which in 14 (standard map) and 15 cases (adapted map) the level of segmental nerve block
corresponded with the dermatomal area. In 3 and 2 cases the segmental nerve block was 
performed at a spinal level not represented in the painful area. In 55% (standard map) 
versus 75% (adapted map, P < 0.005) the combination of spontaneous pain, hypoaesthesia,
and paraesthesias was found in the corresponding dermatome.
Discussion
The mean hypoaesthetic surface area in the corresponding dermatome with the 
standard maps was half (26%) of the mean area found using the adapted dermatomal map
(52%; P < 0.01, paired t-test). This is a direct consequence of the characteristics of the maps:
each locus on the standard map is always represented twice on the adapted map. It is,
nevertheless, remarkable that on both maps the dermatome representing the greatest part
of hypoaesthesia generally is not the dermatome corresponding to the blocked segmental
nerve. This was only found in 11 (standard map) and 12 (adapted map) of the 40 test blocks.
In most cases using the standard and adapted dermatomal maps, hypoaesthesia after
single segmental nerve block was found in at least 2 dermatomes (range 1 to 6). The mean area
of hypoaesthesia interpreted in the standard map differed statistically significance from 
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the adapted map areas (2.7 ± 1.4 dermatomes, standard v 3.6 ± 1.8 dermatomes, adapted
map; P < 0.001, paired t-test). In 6 cases, no hypoaesthesia was found. Therefore, single 
segmental nerve blocks, as applied in the present study, seem to have a limited selectivity
with regard to sensory changes. In the cases where no hypoaesthesia was found, the pinprick
method might have been too insensitive to detect hypoaesthesia, or hypoaesthesia did not
develop at all, or the effect was concealed by overlap by neighboring dermatomes.
The finding of hypoaesthetic areas exceeding 1 dermatome might be surprising,
but it is actually a normal representation of the extensive receptive fields of 1 segmental nerve.
In this way, the peripheral nerve branches of 1 segmental nerve intermingle with similar
branches of the sub- and suprajacent segmental nerves, as already described by Bolk 7.
Sherrington 8,15 also described an overlap in skin innervation and showed that most 
cutaneous loci were supplied by 2 or 3 consecutive posterior roots. This was corroborated
in dogs by Fletcher and Kitchell 16. Foerster 14 confirmed overlap in human dermatomes using
3 different methods: Sherrington’s "remaining sensibility method"; the Strickers and 
Bayliss method 14, dermatomal vasodilatation by faradic stimulation of the distal part of
a divided posterior nerve root; and finally his own "constructive method"- when a series 
of contiguous roots is divided, the superior border of the resulting anaesthesia represents
the inferior border of the dermatome corresponding with the next higher intact root,
while the inferior border of the anaesthetic area represents the superior border of the next
lower dermatome. Finally, overlap of innervation was shown in various animals by several
other investigators 17-23.
The extent of hypoaesthesia over more than 3 dermatomes may be related to 
undetected epidural or distal spread of local anaesthetics during injection, although this was
controlled visually. Epidural spread was only seen in 2 cases that were excluded. A second
explanation might be the way in which the adapted map was constructed. We assumed an
overlap by 2 halves of neighboring dermatomes. However, a more extensive overlap might
exist, as, for example, suggested by Fletcher and Kitchell 16.
Other factors may also contribute to inaccuracies in the findings with respect to 
hypoaesthesia. The conversion from skin to map may lead to a shift. The pinprick method is
rather insensitive in assessing the extent of the vital sensory changes. It cannot discriminate
between subtle differences with respect to lower and higher tactile thresholds 16. More 
precise outcomes can possibly be obtained when applying a modified Von Frey-hair test:
e.g., Semmes-Weinstein 24,25.
Nitta et al. 12 studied spinal nerve blocks by applying lidocaine to the spinal nerves L4,
L5 and S1 and tested the sensory system by using the writing brush method. They found
distinctive regions including the medial side of the lower leg (L4), the posterior side of the
great toe (L5), and the fifth digit of the foot (S1). In 43%, 44% and 92% (L4-S1), respectively,
Nitta et al. 12 found bandlike zones from the posterior midline of the trunk to the periphery
formed by regions of sensory impairment. Their findings are in agreement with the theory
of Keegan and Garrett 9 with respect to the bandlike dermatomes. In the present study,
the same regions were found included in the hypoaesthetic areas. However, the highest 
frequency of hypoaesthesia were found in the lateral thigh and anterolateral side of the 
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knee (L4), at the lateral caudal half of the lower leg and lateral ankle (L5), and at the 
dorsolateral thigh, lateral ankle, and lateral side of the foot. (S1). Only the latter is in agree-
ment with the findings of Nitta et al. 12 Furthermore, we discerned bandlike hypoaesthetic
zones in many individual cases, but after superimposition of all total hypoaesthetic areas we
found quite extensive regions, as depicted in the intensity maps. However, regions with 
higher intensities tend to form bandlike zones as well. Nitta et al. 12 present bandlike zones but
do not give any description of superimposition of the total hypoaesthetic areas. Furthermore,
they used lidocaine at a volume and concentration twice as high as that used in our study
and did not describe any control of spread of their study drug after injection.
In contrast, superimposed areas with paraesthesias were generally of limited size and
showed a more bandlike pattern in comparison to hypoaesthetic areas. The discrepancy 
between the occurrence of paraesthesias and hypoaesthesia in the corresponding dermato-
me can possibly be explained by the more local effect of electrostimulation on the neural 
tissue. The effect of the injected local anaesthetic also depends on many pharmacokinetic
and pharmacodynamic factors. Although the methodology differs, our findings of regions
with paraesthesias seem to fit with those of Nitta et al. 12 for L4, L5 and S1. Also, the locations
representing the highest density of superimposed paraesthesias correlate quite well for 
L5 and S1, with the highest incidence of hypoaesthesia for L5 and S1 in the study Nitta et al.
Only paraesthesias after neurostimulation at L4 remain more anterior in the lower leg in 
our patients.
The frequency of hypoaesthesia and paraesthesias in the corresponding dermatomes
(Fig 6) was equal for the standard map (80%). For the adapted map these figures tend to be
somewhat better: 98% (paraesthesias) versus 88% (hypoaesthesia; P = 0.1, paired t-test).
Comparison between both maps for frequency of paraesthesias in the corresponding 
dermatome shows a significantly higher score for the adapted map (98% v 80%; P < 0.01,
paired t-test), stressing the significance of including neighboring dermatomes in 
dermatomal maps.
Whereas this study was primarily directed toward the interpretation of the sensory
effects caused by segmental nerve blocks, some remarks can be made with respect to pain.
Using the adapted map, pain was present in 1 dermatome (mean ± SD: 2.4 ± 1.3) in only 
11 cases, while using the adapted map pain was always present in at least 2 dermatomes 
(mean ± SD: 3.4 ± 1.0). The extensive areas representing pain in most cases, and the 
multisegmental innervation pattern (each dermal locus is supplied from 3 adjacent spinal
levels), reemphasize the need to perform diagnostic segmental nerve blocks at more than 1
level to obtain insight into the effects on pain. However, after blocking 40 single segmental
nerves, in 6 cases no sensory changes could be demonstrated at all. In 2 of these cases, a 
significant decrease in pain was experienced: in one, the segmental nerve, block was 
performed at a level represented in the pain area, and in the other case the block was 
performed at an adjacent level. In both cases there was no difference between the standard 
and the adapted map. In the 4 remaining cases pain did not diminish, while the block was 
performed at a spinal level corresponding with the painful area. These phenomena 
underline the complexity of pain transmission.
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Although all patients had been diagnosed as “radicular syndrome without neurological
deficit”, this does not mean that all patients should have a pathophysiological process 
comprising the segmental nerve. Other sources of pain might be considered 1,13. However,
the mechanism and interpretation of the effects of diagnostic lumbosacral segmental nerve
blocks was the primary issue of the present study, and not pain or pain reduction. Questions
remaining are the influence, type, and concentration of local anaesthetic drug, the minimal
volume needed, and consequences on extension, duration, and quality of block of mixing 
a local anaesthetic agent with radio-opaque fluid. Also, the position of the tip of the needle
is critical for the spread of the study solution. Particularly, the position of the tip of the 
needle relative to the foramen is of paramount importance obtaining a selective spinal nerve
(and ganglion) block 1. Placing the needle tip too medially can result in epidural spread.
A refinement of the projection procedure in computing the area of hypoaesthesia from skin
to paper needs further study. Furthermore, we are aware of the rather small number of cases
included in this study.
Nevertheless, the results contribute to a further elucidation of the mechanism and
role of the segmental nerve blocks. With respect to the use of dermatomal maps, the fre-
quency of hypoaesthesia and paraesthesias in the corresponding dermatome are significant-
ly higher in the adapted map compared with the standard map. As stated earlier 11 dermatomes
should not be considered as static, but need to be regarded as neurophysiological entities.
In our opinion, a dermatomal map in which neighboring dermatomes are included is more
concordant with this principle, as shown by the significant higher scores of combined presence
of spontaneous pain, hypoaesthesia, and paraesthesias in corresponding dermatomes.
Conclusion
After segmental nerve block, a large variability in size and location of hypoaesthetic
areas is found that is much more variable than considered until now; hypoaesthesia shows 
also more variability compared with elicited paraesthesias. This seems to be in accord 
with the overlapping innervation pattern of dermatomes and reemphasizes the fact that 
dermatomes are more extensive than depicted in standard dermatomal maps. Confirmation
of an adequately performed segmental nerve block, as determined by coexistence of
hypoaesthesia, elicited paraesthesias, and pain in the presumed dermatome, is more reliable
when the overlap of neighboring dermatomes is taken into account.
Further studies are necessary to enhance the technique of the segmental nerve 
block, to find the optimal mixture of drugs used in the spinal nerve block, and to elucidate
the clinical significance of the adapted map.
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4.1
Summary 
Introduction. The present preliminary study documents the effects of a Selective 
Nerve Root Block (SNRB) with short or long acting local anaesthetic compared to baseline
measurements in patients with chronic low back pain radiating to the leg with maximum
pain in one dermatome (L4).
Methods. Ten consecutive patients underwent 20 controlled SNRBs at L4 with 
ropivacaine 0.25% and lidocaine 1% in a prospective, randomized, double blind, crossover
fashion. Baseline measurements included sensory function (assessed by pinprick on 
both unaffected and painful leg) and pain (Verbal Numeric Rating Scale; VNRS, 0-10).
A change in size of areas with altered sensory function above 10% and a VNRS change of
≥ 2 points were considered clinically significant. P values < 0.05 were considered statistically
significant.
Results. Asymptomatic hypoaesthesia, variable in extent and non-dermatomal in
distribution, was present in 7 patients at baseline. It appeared to be more extensive and distal
with longer duration of preexisting pain. SNRB produced no consistent changes in extent
and distribution of hypoaesthetic areas. Change in VNRS did not correlate with the extent 
of pre- or post block hypoaesthesia. No differences in effects were found between lidocaine
and ropivacaine.
Conclusions. Pre block assessment of sensory function is essential to assess the net
effect of SNRBs. In this small study group, SNRBs failed to demonstrate uniform or distinct
effects on sensory function.
4.2
Introduction
In many patients suffering from chronic low back pain radiating to the leg (CLBP-r),
diagnosing the underlying cause is problematic, since no clear patho-anatomic process 
can be identified. Segmental nerve root blocks (SNRBs) have been suggested as a means to
identify the “symptomatic” spinal nerve segment, and are typically used for diagnosis and
prediction of the outcome of surgical or invasive pain treatment 1-9. In earlier studies we 
measured the effects of SNRB on sensory 10 and motor function 11 and found a large variabili-
ty in effects. However, insight into the net effect was not obtained since no baseline measu-
rements were made. In view of the altered sensory processing (neuroplasticity) described in
a variety of chronic pain conditions 12-15, such alterations may also be expected to be present
in CLBP-r patients. Clearly, if sensory function is already altered pre SNRB, this will influence
interpretation of SNRB outcomes. To date, however, neither extent nor distribution of
pre-existent sensory changes, nor how they are affected by SNRB 16 has been formally studied.
The present preliminary study documents the alterations in sensory function present
prior to the SNRB, and the effects of subsequent SNRBs on sensory processing. We used 
the pinprick method, a non-quantifying sensory test, but suitable for mapping.
Patients and methods
Patients were consecutively recruited from referrals to our pain clinic for symptoma-
tic invasive pain treatment. All patients had been examined extensively by (experienced)
neurologists and/or orthopaedic surgeons, including CT, MRI and EMG and were diagnosed
as having chronic low back pain unilaterally radiating beyond the knee. According to our
standard hospital protocol such patients are subjected to a series of diagnostic lumbosacral
SNRBs. Patients with maximum pain in dermatome L4 were included in this prospective,
randomized, double blinded, crossover pilot study. Patients were recruited in accordance
with the rules of the Declaration of Helsinki. The Hospital Ethics Committee approved the
study. Written informed consent was obtained from each patient.
Inclusion criteria were: over 18 years of age, pain present for at least 6 months, and 
a Verbal Numeric Rating Scale (VNRS; 0 is no pain, 10 is intolerable pain) score of ≥ 5 at the
moment of inclusion in the study. Exclusion criteria were: planned surgery, symptomatic
neurological deficits, known hypersensitivity to amino-amide-type local anaesthetics or 
iodide, presence of blood coagulopathy, or mental disorders. All included patients were 
scheduled for test blocks with local anaesthetics at spinal level L4. Each patient underwent,
on separate occasions, two test blocks with commonly used local anaesthetic agents in 
random order, one with lidocaine 1% and one with ropivacaine 0.25%, as each other’s 
control to raise the validity of the block response. We assumed the ratio for the relative 
anaesthetic potencies for lidocaine and ropivacaine to be 1:4 17. The duration of effect was
not a study goal. The hospital pharmacist performed randomization for the first L4 
treatment with lidocaine or ropivacaine via sealed numbered envelopes. The second test block
at L4 was performed on another day with the other drug.
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Three anaesthesiologists specialized in invasive pain treatment performed the 
blocks. A research fellow, unfamiliar with the local anaesthetic agent used, assessed sensory
function 30 minutes before and 30 minutes after the SNRB. The patients’ sensation was tested
by pinprick (HypoR, 825044A, 27G, MPL Technologies Inc., Franklinpark, IL USA) by 2 cm
interval circles from the distal end of the feet up to dermatome T12. The patient was asked
to state whether sensation was normal, less or more intense compared to the unaffected leg.
Areas with sensory changes, if present, were marked and photographed digitally (Sony 
MVC-FD7) with a ruler for calibration. Sizes of areas were calculated with a specially 
developed software program (JvE). A change in area size of less than 10% was considered
clinically insignificant. Pre- and post block VNRS pain scores were also recorded. A 
decrease in VNRS score ≥ 2 points was considered clinically significant 18.
SNRB was performed under fluoroscopic guidance using sensory and motor 
electrostimulation with frequencies of 50 Hz and 2 Hz, respectively, for spinal nerve root
identification. After visualizing the nerve root by using 0.3 ml contrast dye (Omnipaque®
180 mg/ml; Nycomed Ireland, LTD, Cork), 0.7 ml of the study solution (lidocaine 1% or
ropivacaine 0.25% - Astra Pain Control AB Södertälje Sweden - with Omnipaque® 15%) was
injected. For a more detailed description of the SNRB procedure see Wolff and colleagues
(10). All data were initially processed using Microsoft Excel 2000.
Statistical analysis
Changes in size of area with altered sensory and pain VNRS were analyzed by Statistica
software package (Release 6, Statsoft Inc., Tulsa OK 74104, USA). Using Mann Whitney 
U testing we compared pre and post block areas and pain for the grouping variables lidocaine
vs. ropivacaine and block order. Comparison of pre vs. post block VNRS was performed by
Wilcoxon matched pair testing, and pre and post block areas were compared using Friedman’s
1-way ANOVA. Relationships between pain and size of areas were tested using Spearman cor-
relation. The relationship between duration of complaints and pre-block summed hypoaesthetic
areas was assessed by linear regression analysis. P values < 0.05 were considered significant.
Results
Ten patients (6 male, 4 female, mean age 47 yr, SD 12, range 25-63) were included to
undergo a total of 20 SNRBs. Patient characteristics and details of their medical history are
presented in table 1.
Baseline measurements
In 7 patients areas with hypoaesthesia for pinprick were found in the affected limb
before both blocks, but in three patients no pre block hypoaesthesia was detected. In none 
of the patients was hypoaesthesia observed in the unaffected limb. No patients showed 
hyperaesthesia in the affected or unaffected limb. In all patients hypoaesthetic areas did 
not correspond to the pain radiation pattern, and showed a non-dermatomal distribution
(figure 1 and table 2).
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The median pre block pain VNRS was 5 (interquartile range or IQR 4-7 [range 2-8]).
In 3 cases, pre block VNRS scores differed at least 2 points between first and second 
session (patients 1, 5 and 9), but for the group as a whole the difference between sessions 
1 and 2 was not significant. No major differences were observed in mean sensory or 
motor electrostimulation thresholds between the two sessions, but sensory thresholds were
significantly lower when the number of painful dermatomes was higher (Spearman R = 
-0.56, P<0.05). There was no relation between the level of electrostimulation thresholds 
and pre block VRNS.
Table 1 Patient characteristics and medical history
Patient m/f, Duration Radiological Spinal Previous surgery Medication 
age complaints diagnosis level 
[yr] [months] (MRI, CT, X-ray)
1 f, 50 24 facetarthrosis, L5-S1 - NSAID,
spondylarhrosis            codeine
bulging disc, L4-5
rupture annulus      
2 m, 52 144 facetarthrosis, L3-4 2 x laminectomy acetominophen
lateral recess,
spinal stenosis          
epidural fibrosis L2-3
3 f, 63 60 lateral L4-5 4 x hernia operation acetaminophen
facetarthrosis,
herniated disc
4 f, 25 18 bulging disc L4-5 - acetaminophen
5 m, 58 360 lateral recess, L4-5 - NSAID
spinal stenosis
6 m, 53 8 herniated disc L3-4 - acetominophen
7 m, 40 12 herniated disc L5-S1 - acetominophen
8 f, 42 36 bulging disc L4-5 - acetaminophen,
herniated disc L5-S1 codeine
9 m, 30 108 herniated disc, L4-5 chemonucleolysis NSAID
discopathy 
discopathy S1-S2 




Figure 1 Dermal maps presenting areas with hypoaesthesia for pinprick before and after the two sessions with SNRB,
grouped per patient. Each group of figures represents, respectively, the measured areas before the first SNRB
(I-pre), before the second block (II-pre), after the first block (I-post) and after the second block (II-post).
Left legs represent the ventral part of the affected leg, right legs the dorsal part.
Table 2  Results
Patient No 1 2 3 4 5 6 7 8 9 10
Duration of pain [mnths] 24 144 60 18 360 8 12 36 108 120
1st SNRB
1st Local anaesthetic ropi lido lido ropi lido ropi lido ropi ropi lido
Pre-block hypoaesthesia-1 [mm2] 253 1082 495 0 593 0 0 223 1364 1271
Post-block hypoaesthesia-1 [mm2] 69 1085 637 0 591 0 0 394 986 1489
∆ area (%) -73 0 +29 0 0 0 0 +77 -28 +17
Pre-block hypoaesthesia-1 dermatome L1-4 L3-S2 L3-S2 0 L4-S2 0 0 L3-5 L2-5 L3-S2
Post-block hypoaesthesia-1 dermatome L2-4 L3-S2 L3-S2 0 L4-S2 0 0 L3-S2 L2-5 L3-S2
∆ NRS  1 -3 0 -8 0 -1 -3 -4 0 -5 -1
2nd SNRB
2nd Local anaesthetic lido ropi ropi lido ropi lido ropi lido lido ropi
Pre-block hypoaesthesia-2 [mm2] 512 653 237 0 1474 0 0 789 1014 1418
Post-block hypoaesthesia-2 [mm2] 210 659 209 0 1485 0 0 951 1418 1420
∆ area (%) -59 0 -12 0 0 0 0 -59 40 0
Pre-block hypoaesthesia-2 dermatome L1-5 L3-S2 L3-5 0 L4-S2 0 0 L3-S2 L2-5 L3-S2
Post-block hypoaesthesia-2 dermatome L2-4 L3-S2 L4-S1 0 L4-S2 0 0 L2-S1 L2-5 L3-S2
∆ NRS  2 0 0 0 -2 -3 0 -3 0 -6 0
Summed pre block areas [mm2] 765 1735 732 0 2067 0 0 1012 2378 2689
Summed post block areas [mm2] 279 1744 846 0 2076 0 0 1345 2404 2909
∆ Summed hypoaesthetic areas -64 +0,5 +16 0 +0,4 0 0 +33 +1 +8
4.6
Post-SNRB measurements 
In patients with a baseline hypoaesthesia, SNRB produced variable, but neither 
statistically nor clinically significant changes in extent and distribution of hypoaesthetic 
areas (figure 1 and table 2). There was no group statistical difference in total post block 
hypoaesthetic area between session 1 and 2, even when patients without hypoaesthesia were
excluded. Hypoaesthesia was absent in the non-affected limb, hyperaesthesia was absent 
in both legs.
Post block, median pain VNRS decreased from 5 (IQR 4-7 [2-8]) to 4 (IQR 1.5-5 
[0-8]). Median change in VNRS was –1 (IQR –3-0 [–8-0]) and was not different between
the two sessions. Change in VNRS did not correlate with pre block pain VNRS or the extent
of pre- and post block hypoaesthesia. Clinically significant pre-post block decreases in VNRS
(≥ 2 points) were found in 8 of the 20 SNRB sessions (table 2).
No differences were found for lidocaine vs. ropivacaine or for first vs. second 
treatment with respect to pre and post block incidence and extent of hypoaesthesia or for
changes in pain VNRS.
Discussion
Most patients in this small preliminary study had pre-existing hypoaesthetic areas in
the affected limb, not corresponding to pain radiation patterns and non-dermatomal in
distribution. This suggests that for correct SNRB interpretation, post block sensory assessment
alone is insufficient. The net hypoaesthetic effects of SNRBs were neither consistent nor 
significant, and a clinically significant pain reduction was only found in a minority of blocks.
As far as we know, this is the first time that such effects have been described. Earlier
reports 10,14,15,19 have described pain-induced changes in pain thresholds and motor function 
in patients with CLBP-r as well as in chronic cervicobrachialgia patients 20,21. However, these
studies provide no information regarding size and variability of hypoaesthetic areas. A clear
explanation for the baseline presence of hypoaesthetic areas in CLBP-r patients cannot 
be given. However, this phenomenon of areas not concordant with known innervation 
territories of nerve roots, is in keeping with reported extraterritorial spread of sensory 
dysfunction in chronic neuropathic pain patients 22. We have interpreted these areas as 
non-dermatomal in distribution, although one could also argue that this distribution is 
perhaps the result of the patients not displaying dermatomes with definite, fixed 
boundaries. Furthermore, CLBP-r patients should be considered to form a heterogeneous
population in which involvement of adjacent spinal levels cannot be excluded. Moreover, pre
block hypoaesthetic areas often differed before blocks in our study, suggesting spontaneous 
variability in sensory function. Thus, the interpretation of sensory dysfunction and SNRB
effect on sensory function remains extremely difficult.
Two possible mechanisms may be proposed to explain the presence of these 
hypoaesthetic areas, namely nerve damage (small fibre neuropathy) and/or inhibitory 
neuroplasticity.
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We cannot exclude small fibre neuropathy. The pattern of changes we found is 
typical for this, with its presentation of pain accompanied by patchy and asymmetrical 
sensory changes. Pathological processes in the dorsal ganglion, such as demyelinization 
or ion channel re-distribution15, are held responsible for this type of small fibre neuropathy 23,
but identification of such processes was not possible in our patients. To formally establish
the diagnosis of small fibre neuropathy, more specific complementary diagnostic tests 
assessing somatic and autonomic fibre system would be necessary (23).
It is well-accepted that various forms of neuroplasticity can accompany pain 
chronification 13,24. When we grouped our data according to duration of complaints, the 
summed pre- block hypoaesthetic areas appeared to be larger in size and more fixed when 
the duration of pre-existing pain was longer (R = 0.67; p=0.03; figure 2).
Figure 2 Relationship between duration of complaints and extent of summed pre-SNRB hypoaesthetic skin areas (n=10)
Further support for the involvement of neuroplasticity is found in our observation
that electrostimulation thresholds were significantly lower when the number of painful 
dermatomes was higher, indicative of pain-induced central sensitisation. Thus it is tempting
to postulate that the extent, the variability and the location of the hypoaesthetic areas may be
time-related to increasing chronicity of the painful condition. However, considering the small
numbers of patients in the present study one should be cautious. This hypothesis needs to be
formally explored further by studying a large population of CLBP-r patients covering the
complete spectrum of short to long existing chronic pain. Because pinprick testing alone
may miss sensory changes, the use of Quantitative Sensory Testing (QST) in this context
offers the possibility of detecting more subtle differences and acquiring more quantified
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Lack of distinct SNRB effect
The lack of a distinct net effect of SNRB is surprising in view of the generally assumed
axiom that SNRB should lead to dermatome related hypoaesthesia and correlated pain 
reduction. SNRB effects may remain unexpressed because of overlap with neighbouring 
dermatomes 25. Other reasons may include the small number of patients or technical failure,
although all blocks were performed under fluoroscopic guidance and were accompanied 
by clear paraesthesias and muscle contractions. Furthermore, radiological control demon-
strated that in all cases the study drug reached the segmental nerve root L4 without 
unintended intravascular injection or epidural spread. It is conceivable that a more consistent
post block hypoaesthesia pattern would have been revealed if larger local anaesthetic doses
had been used. Complete abolition of intercostal somatic sensory evoked potentials 
(SSEP) was reported in thoracic paravertebral blocks using bupivacaine 26 in high doses 
(bupivacacaine 0,5% 1.5 mg kg-1). Equivalent inhibition of SSEPs has not been achievable
with epidural and spinal anaesthesia 27-29. The volume and concentrations of local anaesthetics
that we administered were within commonly used equipotent range, although to our 
knowledge no controlled dosage-effect studies have been performed up to now in this 
context 16,9. Agents, such as steroids, when added to local anaesthetics in SNRBs are also 
responsible for pain relief 30 and can potentiate a local anaesthetic blocking effect 31. Our study,
however, was aimed at the effects of local anaesthetics only. Differences in pharmacokinetic
behaviour between the two study drugs 16, e.g., differential sensitivity to local anaesthetic
agents by different-sized neural fibres, are not addressed by this study, but cannot be ruled 
out. SNRB effects might further be attenuated by the inability to block alternative sensory
pathways that are part of a multisegmental neural network 32,33. Clearly, our results need 
confirmation with a larger number of subjects.
Conclusion
In this preliminary study SNRBs failed to demonstrate uniform or distinct effects on
sensory function. Prior to the block, asymptomatic hypoaesthetic areas, non-dermatomal 
in distribution, were observed in many patients. In patients with longer duration of pain,
pre block hypoaesthetic areas tended to be larger. Post block assessment only must be 
considered insufficient for SNRB assessement, since much of the observed hypoaesthesia was
already present prior to the block. Careful pre block assessment of sensory function is an
essential prerequisite for interpretation of SNRB effects.
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5.1
Summary
Introduction. Selective segmental nerve blocks with local anaesthetics are applied for
diagnostic purposes in patients with chronic back pain to determine the segmental level of
the pain. We performed this study to establish myotomal motor effects after L4 spinal nerve
blocks by lidocaine and ropivacaine and to evaluate the relationship with pain.
Methods. Twenty patients, of which 19 finished the complete protocol, with chronic
lumbosacral radicular pain without neurological deficits underwent segmental nerve blocks
at L4 with both lidocaine and ropivacaine. Pain intensity scores (verbal numeric rating 
scale, VNRS) and the maximum voluntary muscle force (MVMF; using a dynamometer
expressed in newtons) of the tibialis anterior and quadriceps femoris muscles were 
measured on the painful side and on the control side.
Results. Median VNRS decrease was 4.0 (p<0.00001; Wilcoxon) without significant 
differences between ropivacaine and lidocaine (Mann Whitney U-test). A difference in 
effect on MVMF was found for affected versus control side (P=0.016, Tukey test). Multiple
regression revealed a significant negative correlation for change in VNRS score versus 
change in median MVMF (Spearman R =  -0.48: P = 0.00001).
Conclusion. This study demonstrates that in patients with unilateral chronic low back
pain radiating to the leg, pain reduction induced by local anaesthetic segmental nerve 
(L4) block is associated with increased quadriceps femoris and tibialis anterior MVMF,
without differences for lidocaine and ropivacaine.
5.2
Introduction
Selective segmental nerve blocks with local anaesthetics are applied for diagnostic
purposes in patients with chronic back pain to determine the segmental level of the pain 1-5.
Most patients with chronic pain are treated in day-care and must therefore have sufficient
motor control to be discharged. In many pain clinics, lidocaine is used because of its 
intermediate-acting effect. Ropivacaine, a long-acting local anaesthetic, provokes a less 
intense motor deficit than bupivacaine 6 and possibly also less than lidocaine. These 
pharmacokinetic and pharmacodynamic characteristics of ropivacaine might be of benefit 
in spinal segmental nerve blocks. No reports have appeared on the use of ropivacaine in 
segmental nerve blocks, and, specifically, on its effects on segmental motor function.
In one study, the sensory effects of lumbosacral (L1 to S1) segmental nerve blocks 
by local anaesthetics were found to exhibit 7 a large variability in size and location of
hypoaesthetic dermal areas, but with less variability for elicited paraesthesias. It was 
concluded that for a proper segmental diagnosis, one should also consider the overlapping of
neighbouring dermatomes 6,8-11. Determination of loss of motor function is equally part of
the diagnostic segmental evaluation in invasive pain treatment. Because myotomes are 
also innervated multisegmentally 8, overlap of muscular innervation and the recruitment of
inactive motor units 12 could theoretically mask motor deficits after segmental nerve blocks
by local anaesthetics. A decrease in pain might further contribute to an increase in motor
function, because motor function can be inhibited by pain 13,14.
This study focused on the motor effects induced by L4 spinal nerve blocks with 
lidocaine 1% versus ropivacaine 0.25%, assuming a ratio of 1:4 for the anaesthetic relative
potencies for lidocaine and ropivacaine 6. The fourth lumbar segmental nerve was chosen
since it is the main motor supplying nerve for two muscles whose force can easily be 
measured (i.e., the quadriceps femoris and tibialis anterior muscles). The aims of this study
were: 1) to establish whether there is also large variability in motor effects after L4 spinal
nerve blocks by local anaesthetics; 2) to compare the motor effects of the ‘standard’
local anaesthetic lidocaine versus equipotent doses of ropivacaine; and 3) to evaluate the 
relationship between pain intensity and the effect of a segmental nerve block on motor 
function. Assessment of duration of effect was not a study goal.
Methods
We consecutively recruited patients with unilateral  chronic low back pain radiating 
to the leg who were referred to the pain clinic for symptomatic invasive pain treatment. All
patients were examined extensively, including computed tomography, magnetic resonance
imaging, and electromyelography, and were diagnosed by a neurologist or an orthopedic 
surgeon as having lumbosacral radicular syndrome without neurological deficit (n= 44).
Inclusion critera were: pain present for at least 6 months and a verbal numeric rating scale
score for pain (VNRS; 0 = no pain; 10 = unendurable pain) of at least 5 at the moment 
of inclusion in the study. According to the hospital’s standard protocol, these patients were
5.3
candidates for a series of lumbosacral segmental nerve test blocks, including L4 (n=22).
Exclusion criteria were: availability of causal therapy, known hypersensitivity to amino-
amide-type local anaesthetics or iodide, presence of blood coagulopathy, or mental 
disorders. Patients were recruited in accordance with the rules of the Declaration of Helsinki.
The study was approved by the Hospital Ethics Committee, and each patient gave written,
informed consent. Two patients refused inclusion in the study. Twenty patients were 
ultimately recruited, of which 19 patients finished the complete protocol. One patient was
excluded because of too much pain during the measurement procedures, as a result of which
the muscle force data became unreliable.
Patients always started their test series with a test block at a level other than L4, which
was used for patient instruction and practice according to the study protocol. All other blocks
were done on separate days. The second test block was performed at L4 with a randomly
assigned local anaesthetic - Xylocaine® 1% (lidocaine) or Naropin® 0.25% (ropivacaine) - and
vice versa for the third block. Randomization for starting with ropivacaine (Group RL) or
lidocaine (Group LR) was done by the hospital pharmacist, who provided closed, numbered
envelopes. At the end of the study period, 20 patients had undergone 40 diagnostic segmen-
tal nerve blocks at L4 according to the experimental protocol. The blocks were performed
by three experienced anesthesiologists specialized in invasive pain treatment. All motor 
function measurements were performed by a research fellow, who was blinded for the type
of local anaesthetic, the painful side, and the side of the nerve block.
After patients arrived in the pain treatment room, 5 minutes before the test block,
the VNRS score was recorded and the patient was positioned prone with a pillow under the
abdomen to decrease lordosis. Under fluoroscopic guidance, the insertion site of the needle
was marked on the skin at the painful side by a pencil. The opposite side was also marked 
symmetrically to prevent unblinding of the observer. After lidocaine infiltration anaesthesia
of the skin, a 10-cm electrode (23-gauge, Top®, Sanofi Santé) was inserted in the dorsocra-
nial quadrant of the intervertebral foramen L4-5 (lateral view) and advanced until the tip
was positioned one third to half way along the pedicle column (anteroposterior view).
To confirm the position of the needle point, an electric current generated by a radiofrequency
pulse- and lesion- generator system (RFG-3B, Radionics, Burlington, MA, USA) was applied,
thereby stimulating the spinal nerve or its dorsal root ganglion (DRG). Paraesthesias were
evoked by stimulating with a frequency of 50 Hz and muscular contractions were evoked 
by stimulating at 2 Hz with a motor stimulation threshold of at least 1.5 times the sensory 
stimulation threshold (0.2-2 V). The anesthesiologist recorded the voltages (0-2 V, as 
displayed on the lesion generator system) necessary to evoke the paraesthetic sensations
(experienced by the patient) and muscular contractions (observed by the anesthesiologist
by seeing and feeling the muscle contractions by hand). Subsequently, 0.3 ml of contrast dye
(Omnipaque® 180 mg/ml, Nycomed Ireland, Ltd, Cork) was injected to confirm adjacency
of the DRG, and radiographs were taken in the anteriorposterior and lateral direction.
Finally, 0.7 ml of the lidocaine study solution (lidocaine 1% and Omnipaque 0.15%) or 
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0.7 ml of the ropivacaine study solution (ropivacaine 0.25% and Omnipaque 0.15%) was
injected. Forty-five minutes after the test block the VNRS was recorded again.
Baseline maximal muscular contraction forces were assessed at least 30 minutes 
before injection. The maximum voluntary forces (MVMF) of the tibialis anterior and 
quadriceps femoris muscles were both measured during a maximal effort of 10 s and 
repeated twice at 5-min intervals to enable muscle recovery. After 30 minutes the whole 
procedure was repeated on the other leg.
To measure MVMF, a special device was developed to perform the exercises in a 
standard way. This device enabled the patient to have a half-sitting and half-lying posture,
which was necessary to optimize the test exercise (Fig. 1). The patient's head was supported by
a pillow in a neutral position. The trunk was held at an angle of 45º to the horizontal and 
supported by an adaptable support for the back. Hips and knees were both flexed to an angle
of 90º. The Microfet hand held Dynamometer™ (Hoggan Health Industries, South Droper, UT,
USA) was fixed in this device to measure the MVMF (in newtons). To test the MVMF of the
quadriceps muscle, the dynamometer was attached just proximal to the ankle, in the midline
between the medial and lateral malleolus. The patient had to extend the lower part of the 
leg at the knee at maximal strength against the fixed dynamometer for 10 s. To test the MVMF
of the tibialis anterior muscle, the dynamometer was attached just proximal to the head 
of the first metatarsal bone. The patient had to flex the foot at the ankle at MVMF for 10 s.
Figure 1 Device developed for experiment exercises. In this position the maximal voluntary contraction force of the
quadriceps muscle can be tested. The dynamometer is attached just proximal to the ankle, in the midline 
between the medial and lateral malleolus.
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The data were processed on using Statistica for Windows (release 4.5, Statsoft Inc.,
Tulsa, OK). A minimal decrease of 2 points in the VNRS score was considered as clinically 
significant 15. Between-group demographic data differences were tested using Student’s 
t-test. Intervention order effect (first versus second treatment), drug effect (ropivacaine 
versus lidocaine), side effect (treatment side versus control side), site effect (motor effect on
quadriceps femoris or tibialis anterior muscle), and dermatome effect (whether maximum
pain was in L4 dermatome) on the median of MVMF were evaluated by analysis of variance
(ANOVA). For post hoc analysis Tukey testing was used.
Nonparametric testing (Mann-Whitney U test and Wilcoxon’s signed rank test) was
used to evaluate pre block versus postblock pain. Spearman regression analysis was used 
to assess the various relationships between pre intervention VNRS, change in VNRS,
change of MVMF, and sensory and motor thresholds (r > 0.3 was considered relevant with
95% confidence; P  < 0.05 were considered statistically significant).
Results
Nineteen (total of 38 segmental nerve blocks) of the 20 patients finished the study.
In all but two cases, hypoaesthesia was found by pinprick in the corresponding dermatome
after local anaesthetic injection. Independent assessment of the radiographs revealed no 
epidural spread of radiocontrast dye.
Table 1 Patient characteristics (n=19)
Age: mean SD, range [yrs] 46.8; 12.3; 25-63
Sex: M/F [n] 10/9
Duration of complaints: mean SD, range [mnth] 49.7; 39.4; 6-244




Previous surgery [n] herniotomy 6
PFD 6
RF-LTrOS 3 






Patient characteristics with respect to sex, duration of complaints, radiological diagnosis, relevant
history of  surgery and medication. Abbreviations: PFD = percutaneous facet denervation; 
RF-LTrOS = radiofrequency lesion of lumbar sympathetic trunk.
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Group RL contained five male and five female patients with a mean age of 48.7 years
(range, 36-66 yr; SD, 10.9 yr); Group LR consisted of five male and four female patients 
with a mean age of 55.7 yr (range, 40-79 yr; SD, 13.0 yr). The differences in age between
groups were not statistically significant (P = 0.23; Student’s t-test). Patient characteristics
are described in table 1.
Table 2 shows the effects of segmental nerve block on motor function and pain,
expressed as relative changes in MFMF and absolute change in VNRS scores, respectively.
Some patients did not show any decrease in VNRS after segmental nerve block, but for the
entire group, the median pain VNRS decrease was  4.0 (before versus after: P < 0.00001;
Wilcoxon’s signed rank test). The median pain VNRS (interquartile range; range) was 7.0
(6.0-8.0; 0-10) pre block and 3.0 (0.5-6.0; 0-8.5) post block. In one case in the RL group, the
patient underwent a segmental nerve block with lidocaine without any pain at that moment.
This case was excluded from further data analysis. There were no significant differences in pre
block VNRS, post block VNRS, and change in VNRS between ropivacaine and lidocaine
(Mann-Whitney U-test). Figure 2 shows the pre- and post injection median MVMF’s on the
affected and on the control side.
Table 2 Results
Affected side Control side
∂ median (%)# ∂ VNRS° ∂ median (%)#
ropivacaine quadriceps -7 (-43, 44;  21) -3.0 (-9, 1;  2.4) 7 (-25, 58;  21)
lidocaine quadriceps -12 (-67, 17; 19) -3.3 (-10, 1; 2.9) 1 (-25, 45; 18)
ropivacaine tibial 4 (-49, 71; 32) -3.0 (-9, 1; 2.4) 3 (-37, 115; 43)
lidocaine tibial -2 (-42, 43; 23) -3.3 (-10, 1; 2.9) 3 (-25, 62; 22)
totals -4 (-67, 71; 24) -3.1 (-10, 1; 2.6) 4 (-27, 115; 24)
Differences between post- vs pre block values of quadriceps or tibial muscle forces [Newtons] and
VNRS (n=19) for the affected and control side, after ropivacaine or lidocaine induced segmental
nerve block at L4. Data of muscle forces are expressed as % change in mean force. Values shown
between brackets are % change of maximal decrease and increase, and standard deviation.
# mean % difference between post- vs pre block values of muscle forces (medians of
3 measures are compared)
° mean difference between post vs pre block values of Numeric Rating Pain Scale (VNRS)
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Figure 2 Box Plot representing median MVMF’s (maximum voluntary mucle forces) at the affected (pain) side vs
control side before and after local anaesthetic induced segmental nerve block at L4. A difference in effect on
MVMF was found for affected vs control side (* P=0.016, Tukey).
Analysis of variance demonstrated no significant effect on MVMF for the following
independent factors: first versus second intervention (i.e., order effect), drug injected 
(ropivacaine or lidocaine), site (quadriceps femoris or tibialis anterior muscle), and whether
the maximum pain intensity was in the L4 dermatome or not (both for the standard 
and adapted dermatomal map) 7. A statistically significant difference in effect on MVMF 
was found for affected versus control side (P = 0.016; Tukey test). When the results were 
pooled (both muscles together) for the affected side, a decrease of the MVMF was found 
for median (mean, 4.2%; range, –65% to 71%; SD, 24.3%) values. For the control side, an
increase was observed for median (mean, 4.5%; range, -37% to 115%; SD, 24.3%) values.
The data were pooled for multiple regression to assess correlations between factors
on the affected side. A significant negative correlation was found for change in VNRS score
versus change in median MVMF (Fig. 3; Spearman R =  -0.48: P = 0.00001): the larger the
decrease in VNRS score, the larger the increase in MVMF on the affected side. No statistically
significant correlations were found for pre block VNRS score versus change in median and
sums of MVMF. Further significant correlations were found for the affected side for pre block
VNRS versus post block VNRS (Spearman R = +0.53; P = 0.000001) and the change in VNRS
score versus post block VNRS (Spearman R = +0.69; P = 0.0000001).
No significant correlations were found either for change in VNRS or for change in
MVMF for the control side. For both sides, there was no significant correlation for pre 
block VNRS score versus sensory and motor electrostimulation thresholds, or for the pre

































Figure 3 Change of mean VNRS vs change of MVMF in percentage of baseline muscle force in newton (affected side).
A negative correlation is found with Spearmans multiple regression (Spearman R: -0.48: p=0.00001).
Discussion
The regression results of the study demonstrate that alleviation of pain by segmental
nerve block with local anaesthetics can be accompanied by an increase of MVMF in the 
musculature innervated by that segmental nerve. The larger the decrease in pain, the larger
the increase in force. This is the first time that this phenomenon has been described in human
subjects undergoing segmental nerve blocks with local anaesthetics. This result was 
unexpected, because one would anticipate segmental nerve block by local anaesthetics to
decrease MVMF. A plausible explanation is that pain causes inhibition of motor function 16
and that when pain decreases, motor inhibition is reduced, in accordance with our results.
However, for the group taken as a whole, the median MVMF on the affected side decreased
after segmental nerve block. This is probably the effect of the cases in which nerve block did
not decrease pain.
Le Pera  et al. 16 demonstrated that tonic muscle pain can inhibit the motor system by
using motor evoked potentials from the right abductor digiti minimi by transcranial magnetic
stimulation of the left primary motor cortex in human subjects. To provoke pain, hyperto-
nic (5%) saline was injected into the right and left abductor digiti minimi, into the right first
dorsal interosseus, and into the subcutaneous region of the right abductor digiti minimi.
Motor evoked potentials were significantly reduced in amplitude during pain induced in the
right abductor digiti minimi and right first dorsal interosseus, but not during pain in the left
abductor digiti minimi or during subcutaneous pain. An ipsilateral muscular and possibly
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δVNRS vs. δMedian (QF+TA) (affected side)
δMedian = -.1714 -.0 412 δVNRS
Correlation: r = -.4428
Regression
95% confid.
a myotomal relationship was suggested. Paik et al. 13 studied the effect of conditioning 
stimulation of a peripheral nerve on responses of spinal dorsal horn cells and motor 
neurones in 16 decerebrate-spinal cats. Noxious mechanical and noxious thermal stimuli
applied to the receptive fields reduced the activity of dorsal horn cells and motor neurones
recorded from a filament of ventral rootlet divided from either the L7 or S1 root. One of the
conclusions the authors reached was that the conditioning stimulation of a peripheral nerve
produced a powerful inhibition of the responses elicited by noxious stimuli, suggesting that
inhibition is an antinociceptive effect. Le Bars et al. 14 described diffuse noxious inhibitory
controls in animals and humans, where neurones in the dorsal horn of the spinal cord can be
strongly inhibited by a nociceptive stimulus applied to any part of the body distinct from
their excitatory receptive fields. Diffuse noxious inhibitory control is most likely sustained 
by a loop which includes supraspinal structures and is therefore different from segmental
inhibition. In both of the phenomenona described above, nociceptive signals can be 
modulated by powerful controls. All above described mechanisms have in common that 
pain can inhibit central and/or motor neurone activity and probably represent natural 
mechanisms meant to protect a subject from further harm. A segmental nerve block 
potentially decreases pain-induced motor inhibition. This might explain the unexpected
increase of MVMF after local anasthestic segmental nerve block-induced pain reduction 
in patients with lumbosacral radiating pain in our study.
The dynamometer we used has a high intraobserver reliability 17,18 and the specially
developed device made it possible to measure MVMF for 10 seconds. Submaximul efforts,
avoided by instruction, increase the risk of not using all motor units and, hence, the possibility
of recruiting motor units of other myotomes 12. When the effort was not done in the proper
way, the measurement was excluded from further data processing, which happened in one
patient. We paid special attention to keep a steady muscle temperature by covering the legs
under wool blankets, thus preventing changes in stimulus conduction 19.
This study could not demonstrate differences in effects on MVMF and pain between
lidocaine and ropivacaine. In all but one case, the local anaesthetics were applied at the 
correct location. In only one case (after injection with ropivacaine) the DRG and its 
segmental nerve could not be visualized with contrast dye. It is possible that lidocaine and
ropivacaine are equally potent in segmental nerve blocks in the applied dosages. However, the
number of patients might be too small to demonstrate such an effect. There seems to be,
except for a theoretical difference in duration of effect (not a study goal), no advantage from
one local anaesthetic over the other.
We would suggest that, on the basis of the results of this study, the value of local 
anaesthetic segmental nerve blocks in diagnosing and predicting interventional outcomes
must be treated with caution. Many factors play a role in causing this uncertainty in this 
context, including our lack of knowledge on the precise mechanisms of pain involved,
the many variants of neurophysiology and pathophysiology, placebo effects, and technical
aspects 20. In this study, we have made attempted to illuminate motor aspects of this 
complex interaction. Further investigation is needed to achieve a better understanding of the
underlying complexity of the effects of local anaesthetic-induced segmental nerve blocks.
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We conclude that in patients with unilateral chronic low back pain radiating to the
leg, pain reduction induced by nerve (L4) block is associated with increased MVMF of
the quadriceps femoris and tibialis anterior muscles. There are no differences in effect on
MVMF between lidocaine and ropivacaine. The larger the pain decreases, the more the
MVMF increases. This study is the first to report these phenomena, which can be important
for the interpretation of segmental nerve blocks.
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SELECTIVE LUMBOSACRAL NERVE ROOT BLOCKS 
AND INADVERTENT EPIDURAL SPREAD: A CAUTION
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Summary
Background. In patients with chronic low back pain radiating to the leg (CLBP-r)
segmental nerve root blocks (SNRBs) are performed to predict surgical procedure outcome
and identify the putative symptomatic spinal nerve. Epidural spread may lead to false 
interpretation, affecting clinical decision-making. Systematic fluoroscopic analysis of
epidural local anaesthetic spread and its relationship to needle tip location has not been
published to date. Study aims include assessment of epidural local anaesthetic spread and its
relationship to needle position during fluoroscopy-assisted SNRB.
Methods. CLBP-r patients scheduled for L4, L5 and S1 SNRB were included in this
prospective observational study. Under fluoroscopy and electrostimulation they received 
0.5 ml of a mixture containing lidocaine 5 mg and Iohexol 75 mg. X-rays with needle tip and
contrast were scored for spread epidurally or to adjacent nerve roots.
Results. Seventy-one patients (18 L4, 29 L5, 24 S1) entered the study, 65 were 
analyzed for epidural spread, 62 for needle position. Epidural spread occurred in 47% of
L4 and 28% of L5 blocks, and inadvertent spread to an adjacent nerve root in 3 blocks 
(5%; L5 n=1, S1 n=2). For lumbar SNRBs the needle was most frequently found in the 
lateral upper half of the intervertebral foramen. Epidural spread occurred more frequently
with medial needle positions.
Conclusion. Fluoroscopically detected epidural spread with lumbosacral SNRBs is
common and at lumbar level more frequent with medial intraforaminal needle positions.
Spread to adjacent nerve roots occurs occasionally. Epidural spread decreases selectivity and
necessitates caution regarding the role of SNRBs in clinical decision-making.
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Introduction
Segmental nerve root blocks by local anaesthetics (SNRBs) are performed to identify
the putative symptomatic spinal nerve 1-7 and to predict the outcome of surgical treatment
in low back pain patients 8,9. There is moderate evidence for the effectiveness of SNRB as a
diagnostic tool in spinal pain disorders with radicular complaints 10 but selectivity and 
specificity of this procedure, as well as the reproducibility of its clinical effects, have been
questioned 11-17. Fluoroscopy and, sometimes, CT are used to guide needle position and to
document spread of radio contrast dye. In patients with chronic low back pain radiating to
the leg (CLBP-r) CT-guided lumbar SNRBs with a low volume of 0.5 ml of contrast dye 
showed epidural spread in 50% and inadvertent spread to adjacent nerve roots in almost
25% of the cases 18. Higher volumes resulted in higher incidences of epidural spread. Epidural
spread outside the area of the segmental nerve root will result in a diminished selectivity of
the block. Up to now epidural spread with SNRB has not been assessed for fluoroscopy,
although at present most SNRBs are performed using this procedure. Furthermore, it is not
known if there is any relationship between needle tip position in the intervertebral foramen
and the occurrence of epidural spread.
This study was performed to assess: 1) the incidence of epidural spread in 
lumbosacral SNRBs using fluoroscopy and 2) to determine if there is a relationship between
the needle tip position in the intervertebral foramen and occurrence of inadvertent spread 
of the injected agent. We applied the lowest volume (0.5 ml) that was used by Castro et al 
to enable comparison of results 18.
Patients and methods
Patients with chronic low back pain unilaterally radiating beyond the knee, planned
for diagnostic lumbosacral SNRBs, were included in this prospective, observational 
study. Patients were recruited in accordance with the rules of the Declaration of Helsinki.
The Hospital Ethics Committee approved the study and informed consent was obtained 
from each patient.
All patients were diagnosed as having a ‘radicular syndrome without symptomatic
neurological deficit’ by a neurologist or neuro- or orthopaedic surgeon after extensive 
examination, including CT, MRI and EMG. Patients were scheduled for diagnostic SNRBs 
at L4, L5 and S1. All patients were over 18 years of age.
Exclusion criteria were: planned surgery, known hypersensitivity to amino-amide-
type local anaesthestics or iodide, presence of blood coagulopathy, or mental disorders.
After arrival in the pain treatment room the patient was positioned prone with a 
pillow under the abdomen to decrease lordosis. The insertion site of the needle was marked
by a pencil on the skin of the painful side. Following infiltration anaesthesia of the skin with
1 ml of lidocaine 1.5% subcutaneously, a 10 cm insulated electrode (23G, Top®, Sanofi Santé)
with a 5 mm insulation-free tip was inserted under fluoroscopic guidance (Philips image
intensifier BV25, Philips, Best, The Netherlands) into the dorsocranial quadrant of the L4 
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or L5 intervertebral foramen (lateral view) and advanced until the tip was positioned 
one-third to half way the pedicular column (AP view). For S1 the needle was advanced in
anterior-posterior direction through the posterior foramen into the caudal spinal canal.
Figure 1 Anatomy
Schematic drawing of lumbosacral spine with nerve roots. A. AP view showing medio- (1), laterocranial
(2), medio- (3) and laterocaudal (4) quadrants. *Posterior foramen S1. B. Lateral view with ventro- (1),
dorsocranial (2), ventro- (3) and dorsocaudal (4) quadrants.
To confirm the position of the needle tip, an electrical current generated by a 
radiofrequency pulse and lesion generator system (RFG-3B, Radionics®, Burlington MA,
USA) was applied, thereby stimulating the spinal nerve root or its dorsal ganglion (DRG).
Paraesthesias were evoked by stimulating with a frequency of 50 Hz and muscular contrac-
tions were evoked by stimulating at 2 Hz. X-ray pictures were taken in anterior-posterior
and lateral direction with the needle in position. Subsequently 0.5 ml of the study mixture was
injected slowly (exclusive the volume of the needle and catheter). The study mixture was
made by mixing Xylocaine 2%® (Astra Pain Control AB Södertälje Sweden) and Omnipaque
300® (Omnipaque Nycomed Ireland, LTD, Cork) in a ratio of 1:1, resulting in 5 mg 
lidocaine and 75 mg Iohexol in 0.5 ml. X-ray pictures in AP and lateral direction were taken
again. Three anaesthesiologists experienced in invasive pain treatment performed the blocks.
Two investigators blinded for the patients and experienced in the interpretation of these 
images assessed the radiographs independently (AW, GG). Disagreements in interpretation
(3 cases) were resolved by discussion. Presence or absence of epidural spread and the position
of the needle in the intervertebral foramen of L4-5 and L5-S1 were recorded for L4 and L5
blocks using the following criteria: contrast dye medial to the medial border of the pedicle
and/or cranial to the caudal border of the upper pedicle 19, both in AP view. For S1 SNRB
only assessment of spread to an adjacent nerve root block was done, since in S1 SNRB 
injection is always in the epidural space.
Needle tip position was assessed pre- and post block by dividing the intervertebral





















laterocaudal; Fig. 1A) and in 4 quadrants in the lateral view (i.e. ventro- and dorsocranial,
ventro- and dorsocaudal; Fig. 1B). Needle tip position for S1 was assessed by dividing 
the caudal spinal canal in a ventral, an intermediate and a dorsal third (lateral view).
Chi-squared testing was used to determine differences in the incidences of epidural spread 
(for L4 and L5) or spread to adjacent nerve root (S1) for different needle positions in medial vs
lateral halves of the intervertebral foramen. Differences were considered significant for p<0.05.
Results
A total of 71 patients were enrolled into the study. Six cases (L4 n=1; L5 n=4; S1 n=1)
were excluded because of poor quality of the images, leaving 65 cases for analysis (L4 n=17,
L5 n=25, S1 n=23). Age, gender and radiological diagnoses are presented table 1. The mean
sensory and motor electrostimulation thresholds were 0.62 V (range 0.10 – 1.40; sd 0.30)
and 1.21 V (0.20 – 3.0; sd 0.66) respectively. In 3 more cases (L4 n=2, L5 n=1) needle tip
position could not be determined because of inadequate X-ray direction, leaving 62 cases
for that analysis.
Table 1 Patient characteristics
All % L4 % L5 % S1 %
pts n / % 65 100 17 26 25 38 23 35
m/f 23/42 8/9 8/17 7/16
Age (mean ± SD, range) 47 ± 13 48 ± 13 48 ± 12          45 ± 13         
(26-81) (26-72) (26-81) (16-72)
radiological diagnosis
herniated disc 22 34 6 35 8 32 8 35
bulging disc 3 5 0 0 1 4 2 9
disc degeneration 19 29 5 29 9 36 5 22
spinal stenosis 4 6 1 6 2 8 1 4
epidural fibrosis 4 6 2 12 2 8 0 0
facet arthrosis 5 8 1 6 2 8 2 9
nerve root compression 3 5 1 6 1 4 1 4
surgery 22 34 5 29 10 40 7 30
Epidural spread
In none of the cases was the post block needle tip position changed compared to 
pre block. Epidural spread was found in 15 of the 42 lumbar cases (36%), 8 at L4 blocks
(47%), 7 at L5 blocks (28%; table 2) and, as expected, in all S1 cases. For L4 epidural spread
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was observed medial to the medial border of the pedicle as well as cranial to the caudal 
border of the upper pedicle in 5 cases (Fig. 2A), for L5 this occurred in 4 cases (table 2).
Spread to adjacent ipsilateral nerve roots was found in 1 L5 block (to S1) and 2 S1 blocks 
(to S2; Fig. 2B).
Table 2 Incidence of epidural spread with SNRB
L4 % L5 % S1 %
pts n, % 17 25 25 41 23 34
Epidural spread
medial to medial border pedicle 8 47 7 28 - -
cranial to caudal border upper pedicle 5 29 4 16 - -
epidural spread 8 47 7 28 23 100
second nerve visible 0 0 1 4 2 9
Figure 2 Fluoroscopy images before and after injection with SNRB
AP view of SNRB prior to (left figures) and just after the blocks (right figures). A level L4, female, 52 yrs 
showing epidural spread medial to medial border of pedicle and cranial to caudal border of upper pedicle
(arrows). B Level S1, female, 45 yrs showing spread to S2 nerve root (arrow). # needle
Needle tip position
Thirty-nine lumbar cases were evaluated for needle position. No differences were observed
between L4-5 and L5-S1 levels. The majority of all needle tips were localized in the 
lateral part of the upper half of the intervertebral foramen (27; 69%) of which 15 (38%) were
located dorsally and 12 (31%) ventrally. The remaining needle tips were found in the lateral
caudal half of the foramen (n=6; 4 ventral, 2 dorsal) and in the medial cranial half of
the foramen (n=5; 2 ventral, 3 dorsal). In 1 case the needle tip was located dorsally in the
mediocaudal quadrant of the intervertebral foramen (table 3).
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Table 3 L4 and L5 SNRB needle position
n=39
Lateral view (quadrant)
ventrocranial dorsocranial ventrocaudal dorsocaudal
mediocranial 2 (2) 3 (1)
laterocranial 12 (4) 15 (6)
mediocaudal 0 1 [1]
laterocaudal 4 (0) 2 (1)
n = blocks; (n) = blocks with epidural spread; [n] = blocks with epidural spread to adjacent nerve root
Table 4  S1 SNRB needle position
n=23 Lateral view of caudal canal
Anterior-posterior view (quadrant) ventral intermediate dorsal
mediocranial 2 3 [1] -
laterocranial 1 11 -
mediocaudal 1 2 [1] -
laterocaudal - 3 -
n = blocks with epidural spread; [n] = blocks with epidural spread to adjacent nerve root
Epidural spread was found in 15 of those 39 lumbar cases evaluated for needle 
position (39%) (tables 3 and 4). For L4 and L5 SNRBs with needle position in the medial 
half of the intervertebral foramen epidural spread was present in 67% of cases (4/6) vs 33%
(11/33) for the lateral half of the foramen (p=0.06, Chi-squared test). Also, the one case 
with epidural spread to an adjacent nerve root showed a medial needle position. There were
no statistical differences with respect to epidural spread for lumbar cranial (13/32) vs caudal
(2/7) and for ventral (6/18) vs dorsal (9/21) intraforaminal needle positions.
For S1 SNRBs, epidural spread to an adjacent nerve root occurred in 33% (2/6) cases
with needle tip in the medial half of the foramen, with no cases of spread to an adjacent
nerve root (0/15) with a lateral needle position (p=0.015, Chi-squared test). No statistical
differences were found for cranial (1/17) vs caudal (1/6) needle positions, and for ventral
























In the present study on lumbosacral SNRBs using fluoroscopy, we observed a high
frequency (i.e., 38%) of inadvertent epidural spread, while extension to an adjacent nerve
root occurred in only a few cases. Epidural spread is more frequent with medial intraforaminal
needle positions and the cases with spread to an adjacent nerve root also showed medial
needle tip positions.
For CT-guided lumbar SNRB, Castro et al 18 demonstrated that epidural spread is 
common in this region. They reported epidural spread in 50% and spread to adjacent nerve
roots in 25% of cases with their lowest volume (0.5 ml). In our study, using the same 
volume of injection fluid - equal to the lowest volumes reported in relevant studies (table 5)
- we found a much lower incidence of spread to an adjacent nerve root. An explanation for
this discrepancy might be our use of electrostimulation to locate the segmental nerves, in
contrast to Castro et al 18. Furthermore, in our study the needle was aimed at the lateral half
of the intervertebral foramen, which position was adjusted according to electrostimulation
parameters. The mean sensory threshold for electrostimulation in our patients was 0.6 V,
which could indicate a mean distance of 3 mm between tip and nerve root 18. Castro et al
reported an overall mean distance between the tip of the needle and the nerve root of 3 mm
as well 18. However, this is debatable, for the 8 mm slice thickness in CT they used implies 
a large partial volume effect, suggesting that their figures might be overestimated.
However, at the same time our results might also be underestimated due to technical
flaws. Fluoroscopy has a lower resolution than CT, which might decrease sensitivity for 
detecting inadvertent spread to adjacent nerve roots and thus induce false-negative results.
Furthermore, since the lumbosacral SNRBs were part of a diagnostic procedure, our 
mixture also contained lidocaine, in contrast to Castro et al 18 who used only contrast dye.
Although they did not mention the concentration of the injected contrast fluid, our 
mixture may be less radiopaque. We mixed lidocaine in a high concentration (2%) with 
300 mg Iohexol, resulting in 75 mg Iohexol per 0.5 ml. In a pilot study this dosage of Iohexol
appeared sufficiently radiopaque to be able to identify epidural spread. Other methods 
that enhance quality of monitoring spread, such as are real-time fluoroscopy and digital 
subtraction of contrast dye before and after injection, might have improved the results for 
epidural spread. However, these aspects are beyond the framework of the present study.
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Table 5 Contrast dye and local anaesthetics used in relevant SNRB studies 
Authors Year Contrast dye mg/ml Volume Local mg/ml Volume
(ml) anesthetic (ml)
Schutz et al 1 1973 Iophendylate NM 1 Procaine NM 1.0
Krempen and Smith 2 1974 Iophendylate NM NM Lidocaine 10 1.0
Krempen et al 20 1975 Iophendylate NM NM Lidocaine 10 1.0
Tajima et al 3 1980 Iothalamate 600 > 2 Lidocaine 10 3.0
Meglumine
Haueisen et al 4 1985 NM NM 1 Lidocaine 10 1.0
Quinn et al 21 1988 Diatrizoates 600 1 Lidocaine 10 3.0
Dooley et al 5 1988 Ethyl NM 1 Lidocaine 10 1.0
Iodoundecylate Mepivacaine
Herron LD 8 1989 NM NP NP Lidocaine 5 - 10 1.0
Bupivacaine
Castro et al 18 1994 Iothalamate NM 0.5- 1- 2 NP NP NP
Hasue et al 19 1989 Metrizamide NM 2 Lidocaine 20 2.0
van Akkerveeken 22 1993 NM NM < 1.0 Bupivacaine 5 0.2 - 0.5
Nitta et al 23 1993 NM NM NM Lidocaine NM 1.5
North et al 12 1996 NP NP NP Bupivacaine 5 3.0
Porter et al 24 1999 NP NP NP Bupivacaine 5 1.5
Manchikanti et al 7 2001 NM NM 0.3-1.0 Lidocaine 20 0.3 - 1.0
Wolff et al 15 2001 Iohexol 180 0,3 Iohexol  + 45 +    0.75
Lidocaine 10
Macadaeg et al 25 2001 NM NM NM Lidocaine 20 0,5 - 0,75
Wolff AP et al 16 2004 Iohexol 180 0.3 Iohexol + 105 +
Lidocaine  or 7 or 0.7
Ropivacaine 1.75
Huston et al 26 2005 NM NM 0.5-2 Lidocaine 20 2.0
Geurts et al 27 2003 Iohexol 240 1.0 Lidocaine 20 0.5
NM = not mentioned; NP = Not Performed
Although the target area of the needle tip was the lateral half of the dorsocranial 
quadrant of the intervertebral foramen, i.e. the so-called safe triangle, the tip was found
elsewhere in 61.5% of the cases. The safe triangle is cranially bounded by the caudal border
of the upper pedicle, laterally by a line connecting the lateral borders of the upper and 
lower pedicle, and medially by the spinal nerve root. It is considered a safe entry zone for the
needle to come nearest to the segmental nerve before starting electrostimulation. Redirection
of the needle based upon electrostimulation criteria will lead to other needle positions than
the initial ones, as shown in this study. These results are in keeping with reported variations
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in localization of lumbar DRGs in relation to the intervertebral foramen 19, e.g., L5 DRG 
localization may vary from extraforaminal to intraforaminal to inside the spinal canal.
Furthermore, alterations in the local anatomy, such as bulging discs, facet arthrosis and 
spinal or foraminal stenoses may contribute to nerve root and DRG displacement.
Our findings suggest that epidural spread is related to medial needle tip position.
Indeed, in four of the six lumbar cases (66%) where the tip was medially located epidural
spread occurred, compared to eleven of the 33 (33%) laterally positioned needle tips. Further,
in all blocks with spread to an adjacent nerve root, the tip of the needle was observed 
medially. It would appear that placement of the tip of the needle in the medial half of the
foramen (L4-5, L5-S1) increases the possibility of epidural spread and, thus, of false 
positive interpretations. Also, needle placement with the tip in the medial half of the dorsal
sacral foramen (S1) increases the risk of spread to an adjacent nerve root. However, in view
of the small numbers, further studies are indicated to confirm these results.
The high incidence of epidural spread with an intraforaminal lumbar block implies
that the local anaesthetic contained in the injection fluid will block adjacent neural 
structures as well: sinuvertebral nerves conveying nociceptive information from the outer
annulus fibrosus, the ventral dura and posterior longitudinal ligament, and nearby 
rami communicantes 29. Since these structures, when inflammation is present, may mimic 
radicular syndromes 30 false-positive results may be induced.
Our study again emphasizes that many lumbar SNRBs are not selective 15-18, even if low
volumes are injected. This stresses not only a need to reconsider their role in the diagnostic
and presurgical selection process of CLBP-r patients, but the necessity of redefining the 
concept of SNRB. The recently suggested matching of provoked nerve root response 
(i.e., paraesthesias provoked by electrical stimulation) with spontaneous pain should 
get more attention 31. Repeat electrostimulation directly after the SNRB, and performing 
the same double electrostimulation procedure before and after block at supra- and 
subjacent levels could further improve insight in the segmental pain pattern. Paraesthesias 
in corresponding dermatomes are reliably reproducible, as we have demonstrated in a 
previous study 15.
Conclusion
The high incidence of epidural spread after diagnostic lumbar SNRB found by 
fluoroscopy results in a decreased selectivity since adjacent spinal structures are also 
blocked, and warrants caution in SNRB interpretation. Inadvertent spread to adjacent nerve
roots can occur in up to 9% of cases. Lumbar epidural spread and lumbosacral spread to an
adjacent nerve root are greater with medial needle position in the intervertebral foramen.
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Chapter 7




SNRBs are performed in patients with specific radicular pain to predict the outcome
of surgical procedures. They are also applied in patients with chronic back pain radiating to
the leg to identify the putative symptomatic spinal nerve if history, physical examination,
imaging and electrophysiological examination are inconclusive 1,2. These CLBP-r patients
represent a large patient population and form a major part of the referral to pain clinics.
Some would argue that such referrals are more or less useless, since SNRB as an additional 
diagnostic tool will not be able to identify nerve root involvement, as a patho-anatomical
cause was not demonstrated in these patients. However, this overestimates the importance of
the diagnostic imaging and electrophysiological techniques. Daily clinical practice shows
otherwise, since there is no clear relationship between imaging results, electrophysiogical 
findings and patient complaints. Even in so-called specific radicular syndromes there is no
absolute consensus on clinical signs and symptoms, critical MRI findings and the structure
that is eventually causing the pain. Only the findings at surgery related to outcome are 
certain. For the above-mentioned group of CLBP-r patients, in which no underlying cause is
or can generally be found, diagnostic insecurity is much higher. Nevertheless, even in this
group of patients with generally negative nerve root MRI findings, the positive finding of an
inflamed nerve root is often found at spinal endoscopy 3. This suggests that at least part of
our diagnostic procedures is still insufficient. For SNRBs the situation is worse: a specific
patho-anatomical diagnosis upon which to base a gold standard can only be made (e.g. during
surgery or spinal endoscopy) in a small part of the population. A gold standard against which
to compare SNRB effects is thus lacking for the larger part of CLBP-r patients. Consequently,
we have to rely upon consistency of the clinical-physiological effects that are induced by
SNRB of segmental nerve root blocks. Surprisingly, data on this are limited 4. Therefore,
the main aim of this thesis was to determine if SNRB effects on pain reduction and on 
corresponding segmental sensory and motor function are consistent in CLBP-r patients.
Patient selection for SNRBs
All patients included in our studies were patients with intractable radiating pain 
who underwent evaluation according to a multidisciplinary model. After an extensive 
history, physical examination and evaluation of radiological imaging results, attempts were
made to establish clinical diagnoses. An algorithm as proposed by Bogduk and McGuirk 5,
and also described in evidence-based practice guidelines for interventional techniques in the
management of chronic pain 2, was used in our patients.
To select patients with specific monoradicular pain for surgery, pain reduction of
100% with SNRB is used as a diagnostic criterion 6, although systematic volume-dose effect
studies on the optimal volume and concentration of the local anesthetic needed for this effect
are lacking. In SNRBs performed in CLBP-r patients, it is not known if pain is uniquely 
the result of changes in the targeted spinal nerve root. Most CLBP-r patients express pain
that is multifactorially determined, consistent with its chronic nature. In these patients it 
has to be established to what degree the targeted spinal nerve root is part of the problem,
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since it is known that radicular pain can be mimicked by referred pain originating from 
nociceptive (peri-)spinal structures such as facet joints, sacro-iliac joints, intervertebral disc
and ventral dura 2,7-13. Furthermore, any epidural spread to adjacent structures needs to be 
identified, implying that the local anaesthetic should be mixed with a highly radiopaque
contrast dye, which is not always the case. Total selective pain relief as standard diagnostic 
criterion may therefore be a utopia. Partial pain relief might be a more realistic goal.
At present, it is unknown which percentage of pain reduction should be used to reliably assess
effects of SNRBs in CLBP-r patients. In our series we adopted a pain reduction of 30% or
minimally 2 points on the Numeric Verbal Rating Scale 14,15 as acceptable for assessing nerve
root involvement in radiating pain.
Because there is no functional gold standard to compare with and because placebo
effect has to be minimized, we used controlled blocks 5,8,16 in studies on L4 SNRBs (chapters
4 and 5). Although we did not evaluate duration of effect, the variability in response to both
local anaesthetics we found questions the usefulness of these controlled blocks, especially
since they are only focussed upon block induced pain reduction. The use of placebo 
(i.e., saline injections) in SNRBs in patients suffering from intractable pain is considered
unethical and was therefore not used in our studies. Another method to improve the 
diagnostic reliability is to perform always SNRBs at minimally 3 spinal levels on separate
occasions. That is also what usually happened to our patients in their individual treatment
sequence. However, this was not part of our study methods.
Complications
In none of our patients complications were reported, however, documentation 
of complications and adverse events was not a primary study goal. Complications can 
occur as with any other invasive action and may be related to needle placement or drug 
administration 2. They include direct trauma to the nerve root, damage to neural vasculatu-
re resulting in haematoma with neural infarction 17 or intravascular injection. Potential major
complications are death, paralysis, spinal nerve injury, infection or allergic reactions. Minor
complications are exacerbation of pain, pain at the injection site, bleeding, dural puncture,
headache and vasovagal responses. Houten and Enrico 18 reported 3 cases of paraplegia after
lumbosacral (2 L3, 1 S1) steroid injection, which was attributed to vascular damage and 
subsequent embolisation of steroid emulsions. In a prospective non-randomized controlled
trial Huston and Slipman 19 recorded complications and side effects immediately after SNRB,
and after 1 week and 3 months. A total of 151 patients underwent 306 SNRBs, and 60 patients
who had not undergone any intervention served as control group for the 1-week evaluation.
The authors reported no major complications with lumbosacral SNRBs. Immediate effects
described as side effects were reported by 39,4% of the patients (pain at injection site, 17,1%;
exacerbation of pain, 8,8%; light-headedness, 6,6%; increased spinal pain, 5,1%; nausea,
3,7%; non-specific headache, 1,4%; vomiting, 0,5%). Surprisingly, after one week no 
differences were observed in incidence of “side effects” between the two groups (9%), except
for pain at the injection site, which was more frequent in the active group. Only one patient
suffered from non-specific complaints after 3 months. This suggests that only pain at the
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injection site can be considered as a temporary side effect. Risk of complications can be 
minimized by performing the procedure in patients who are awake, by using imaging 
techniques such as fluoroscopy, by aspirating through the needle before injection, and by
dynamic imaging of the contrast dye injection that precedes the definite injection.
Main thesis questions and conclusions
In this paragraph the main questions in this thesis as presented in the general 
introduction will be discussed.
What is the present basis for the application of SNRBs in CLBP-r patients? 
SNRBs are applied in patients that complain of radiating pain to the leg with a 
dermatomal distribution. If a patho-anatomic cause is identified, but signs of neurological
deficit and positive spine nerve tension tests are absent, these patients are described as having
radicular pain (chapter 2). If such signs are present, the patients are considered to have a
radiculopathy. In these patients, a high sensitivity, specificity and predictability are attributed
to SNRBs if they are used to predict outcome of surgery, although most studies are retro-
spective 6,20-24. In many of CLBP-r patients, however, a clear patho-anatomic substrate cannot
be demonstrated with the presently available diagnostic tools. Nevertheless, patients may
experience pain that follows a segmental or a segment-like pattern, which pain is best 
described as segmental pain. Presently, data are lacking whether the segmental nerve root
actually generates the pain, but even if this is not the case, we cannot come to a decisive 
conclusion, since the resolution of our current diagnostic tools is insufficient. We cannot at
present fully verify if a root is irritated, and thus we cannot suggest effective therapy for
CLBP-r patients in the absence of a clear view of the patho-anatomic background or degree
of neuroplastic changes. The only basis on which SNRBs might at present be rationally applied
is that a reasonable alternative diagnostic tool is not available. Therefore, it seems logical 
to suggest that the role of SNRBs in CLBP-r patients and the conceptual framework of
“segmental pain” both need to be reconsidered. More sophisticated diagnostic tools clearly
need to be developed to better establish diagnosis in CLBP-r patients.
Are SNRB effects expressed in a dermatome-related fashion? 
A segmental nerve root block is supposed to act on the segmental nerve and should,
therefore, display segmental effects. In our series with lumbosacral SNRBs (chapter 3),
we found that concomitant occurrence of pain, pain reduction, paraesthesias elicited by 
electrostimulation and hypoaesthetic areas was hardly consistent, particularly when related
to the dermatome of the treated segmental nerve root. Furthermore, size and location of post
block hypoaesthetic areas showed a large variability. In contrast, elicited paraesthesias showed
consistent segmental patterns. In 98% of the time they occurred in corresponding extended
dermatomes and in 80% in classic dermatomes. The use of dermatomal maps representing
overlap by neighbouring dermatomes may improve understanding of dermatomal 
representation of pain, paraesthesias, hypoaesthesia and pain.
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Do SNRBs exert consistent effects on sensory function? 
In this study (chapter 4) we tested the consistency of segmental sensory effects of
lumbar SNRBs at one lumbar spinal nerve (L4) with a short acting (lidocaine) and long
acting (ropivacaine) local anaesthetic. We found no clear differences in effects between 
lidocaine and ropivacaine. Since in an earlier study we had observed post block sensory effects
without knowing if pre-block sensory signs were already present in these patients, the net
effect of SNRBs was assessed by comparing pre – and post block sensory measurements.
We found that areas with hypoaesthesia were already present before SNRB in the majority of
the studied CLBP-r patients in a non-dermatomal, mainly distal, distribution. Their size 
tended to be larger if duration of pain was longer. Furthermore, SNRBs did not markedly
affect pre-existing alterations of sensory processing. Thus, SNRBs do not exert consistent net
sensory effects. Until now, we presumed that the block was technically successful if SNRB 
caused hypoaesthesia in the corresponding dermatome. Absence of hypoaesthesia neverthe-
less does not mean that the block is not successful because neighbouring dermatomes over-
lap each other by half 25. Furthermore, pre-existent neuroplasticity may affect sensory function
resulting in non-dermatomal areas of hypoaesthesia before and after block. Therefore, to
evaluate sensory effects caused by SNRBs, it is mandatory that sensory function be assessed
before and after block with the following aims in mind: to establish the presence of neuro-
pathic sensory changes, to establish if neuroplastic changes have occurred and to determine
if the SNRB induced hypoaesthesia is concordant with the corresponding dermatome.
Do SNRBs exert consistent effects on motor function?
SNRBs at L4 variably induced a decrease or increase in maximal voluntary muscle
force in the corresponding myotomes amongst the studied CLBP-r patients (chapter 5).
A non-specific pain reduction with block in the affected limb leads to an increase in muscle
force. SNRB induced motor function alterations do not play a role in monitoring the 
technical SNRB quality and in establishing the putative spinal segmental level in CLBP-r
patients for pain diagnosis. Assessing motor function quantitatively is a complex matter.
It needs standardized circumstances to obtain reliable results. Testing motor function is 
therefore not suitable for monitoring quality and effect of the block in daily practice.
Measuring corresponding myotome related muscle force with SNRB has for the time being
no diagnostic consequences for individuals with chronic radiating low back pain 26 and is 
therefore not advocated in individual assessment.
Is there any role for SNRBs as a diagnostic tool in CLBP-r patients? 
Fluoroscopically monitored inadvertent epidural spread is commonly found in lum-
bosacral SNRBs, whereas extension to an adjacent nerve root is not, although in this study
(chapter 6) the occurrence of spread to adjacent nerve roots may have been underestimated.
In lumbar nerve root blocks epidural spread was observed relatively more frequent when the
tip of the needle was positioned more medially in the intervertebral foramen. This epidural
spread affects selectivity of the nerve root block 27,28. This conclusion is in keeping with 
the results of recently published systematic reviews on the diagnostic utility of selective 
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nerve root blocks 1,2. Limited evidence was found for the effectiveness of a selective nerve root
injection as a diagnostic tool in spinal disorders in the absence of disc herniation and 
negative provocative discography. However, these reports were based upon studies that used
SNRBs as a standard selection tool without systematic measurements of the effects of local
anaesthetics on sensory and motor function.
Our results indicate that evaluation and technique of SNRBs should be altered to make
them a useful diagnostic instrument. In the absence of consistent effects and a gold standard
to compare with, we found support for the idea that matching elicited paraesthesias with 
the patients’ segmental pain patterns (chapter 3) may contribute to the development of a
diagnostic gold standard for SNRBs 29. Haynsworth 30 suggested an algorithm, using both 
electrostimulation and conduction anaesthesia of the spinal segmental nerve root, in which
matched elicited paraesthesias and pain should disappear after nerve root block. This 
procedure can be repeated systematically for various spinal levels within one session. In the
future, more sophisticated diagnostic methods, as spinal endoscopy and high resolution MRI
(> 2.0 Tesla compared to the 1.5 Tesla for standard MRI) may provide the ability to detect
nerve root processes that have remained concealed until now.
In view of potential, albeit usually minor, complications with SNRB 19 - which always
should be taken into account with every invasive procedure - we have to counterbalance the
pros and cons. Despite a lack of knowledge about the basic effects of SNRBs, or perhaps 
just because of this lack of knowledge, we feel that the potential of SNRBs has not been 
fully explored and needs further elucidation. Moreover, the low positive predictive value of
imaging studies 12 and low diagnostic contribution of neurological examination in the chro-
nic radiating low back pain problem 31 make additional interventional diagnostic techniques
necessary. SNRB technique should be adapted to improve segmental selectivity. It justified that
we put all our efforts into improving the diagnostic quality and effectiveness of lumbosacral
SNRBs in CLBP-r patients, because there is no better alternative for the time being.
With respect to needle point positioning in SNRB, the electrode tip can be positio-
ned extra- or intraforaminally. Clearly, intraforaminal tip position has the disadvantage 
that epidural spread may occur resulting in decreased block selectivity. Injection of a local 
anaesthetic with extra- or paraforaminal needle position 32 may lead to anaesthesia of the
mixed spinal nerve that may impair motor function, affecting patients’ ability to provoke
their pain. There are no studies available that describe motor dysfunction after extraforami-
nal block. However, we demonstrated that motor function might increase or decrease after
intraforaminal block in a variable manner (chapter 5). A study comparing motor function
with intra- and extraforaminal SNRB should be conducted to elucidate this subject.
Future work and recommendations
Spinal endoscopy
Various findings and developments, such as identification of involvement of DRG
neurons in radiating pain by spontaneous repetitive firing 33, diagnostic transforaminal 
segmental nerve root blocks 34, interventional treatment of the DRG 35, identification of nerve
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root irritation by autologous nucleus pulposus 36, and (transforaminal) epidural injection of
steroid agents37,38 have contributed to the present concept of segmental radiating pain in patients
without radiologically confirmed diagnosis. Segmental pain, having no clear underlying 
patho-anatomic diagnosis, is thus at present part of a conceptual framework that has to be
reconsidered. Inflammatory processes of the nerve root and DRG 39 may induce radiating pain.
Inflammation may involve surrounding tissues via inflammatory exudates 40. This may be a
further reason why segmental processes exceed dermatome territories. In case of inflamma-
tion, local anaesthetics may not be effective due to altered tissue acidity and should be comb-
ined with steroid agents. Evidence is growing that steroid injections are effective in patients
suffering from radicular pain due to nerve root irritation 41. Studies on establishing a diagno-
sis related to a spinal segmental level may therefore in future include agents that are active on
inflammatory processes. With the available diagnostic tools it is not easy to detect neuroin-
flammation, but spinal endoscopy is a promising modality that provides an opportunity to
observe fibrotic adhesions and inflammatory changes in the epidural space involving 
structures such as spinal nerves, dura and fibrotic adhaesions 3,42-46. Spinal endoscopy enables
us to visualize all this in a fashion that cannot be done yet or achieved by CT or MRI. A direct
view of pathological processes in the epidural space with an opportunity to further diagnose
local processes by taking biopsies and analysing biochemical inflammation markers may help
us to better understand underlying mechanisms. Moreover, a more targeted application of anti-
inflammatory agents is possible in this context 3. Recent developments in imaging techniques
will increase diagnostic resolution enormously, with high-field MRI (7.0 Tesla) having the
potential to eventually monitor in vivo processes in humans with a high spatial resolution 47.
Neuroplasticity
Findings indicating the presence of (chronic) pain induced neuroplastic changes
emphasize that pain is associated with a nervous system subjected to complicated dynamic
processes 48-52. A concomitant result of a systematic observation of SNRB effects on sensory-
, motor function and pain in CLBP-r patients is that the changes observed also provide insight
not only in the mechanism of SNRBs, but also into pain related neuroplastic processes. In our
series we used pin prick to assess sensory function, because it is easy and fast for mapping
areas with changed sensory function. It is commonly used and reliable enough to test 
hypoaesthesia after nerve blocks 53. However, the use of Quantitative Sensory Testing (QST)
techniques will offer greater opportunities for sophisticated assessment 54,55 and will enable
the identification of more subtle changes in sensory pain processing. The assessment by QST
of sensory changes induced by SNRBs in healthy volunteers, and the systematic evaluation of
pain and neuroplastic processes in the acute, subacute and chronic phase of patients via long
term follow up, will most probably lead to a better understanding of (chronic radiating) pain
and underlying mechanisms.
Anesthesiology and pain treatment: a diagnostic challenge? 
Anesthesiology and pain treatment are strongly related to each other on historical
grounds. Attractive medical aspects of both disciplines offer great opportunities to raise
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insights in pain. Until recently, pain treatment was strongly directed to symptom related pain
reduction and less related to the establishment of a diagnosis. Symptomatic treatments such
as intravascular drug injection, direct modulation of the peripheral or central nervous system
with or without indwelling catheters, and the application of potent drugs have been widely
applied. However, pain treatment as a medical field has now entered a challenging pathway
to mechanism-based therapy 50. The growing knowledge in molecular biological, physiolo-
gical and neuro-psycho-social aspects, the development of diagnostic computerized tools,
such as new generation functional MRI, echoscopes, endoscopes, QST, and (infrared) 
thermography, will all together finally change our insight in the mechanisms of pain. This will
fundamentally alter the pain clinicians’ view of diagnosis and therapy. It should further 
be emphasized that, because of its complexity, the solution of the puzzle of pain will only be
achieved via interdisciplinary co-operation.
For this, extended networks of (para-)medics, scientists, government, industry and
investors, and the use of sophisticated ICT platforms are necessary. This should guarantee 
a more efficient development process. The pain clinician has the potential to play a central 
role in this multifactorial approach, if he has a complete overview and has the ability to inte-
grate all relevant developments on pain. Traditional frameworks in health care and medical
science need to be surpassed to further improve diagnosis and achieve effective treatment 
to alleviate the individual and societal burden of chronic pain. A giant challenge is waiting to
be resolved. It is an opportunity that should bring more light to the darkness of pain.
Final conclusions
There is a large variability in the changes of sensory and motor function induced by
SNRB. Multiple factors, such as multisegmental innervation of spinal structures, overlap of
neighbouring dermatomes, chronic pain induced neuroplasticity and epidural spread result
in limited reliability of the blocks with respect to consistency and interpretation of effects.
Of the described concomitant effects after SNRB only paraesthesias induced by electrical
nerve stimulation show a consistent pattern, potentially making these suitable for improving
pain diagnosis and monitoring the technical quality of SNRBs. The findings of this thesis do
not support that SNRB, as presently used, is an adequate diagnostic tool to relate radiating
pain in the leg in chronic low back pain patients to a specific spinal segmental level. Future
work should focus on distinguishing segmental pain from non-segmental (referred) pain by
matching paraesthesias not only to pain at the stimulated level, but also with pain reduction
induced by the nerve root block. Furthermore, the relationship between paraesthesias in 
irritated vs non-irritated nerve roots needs to be established. Selectivity of the nerve root
block should be improved to reduce false interpretations of block outcome. Increasing the
resolution of modern imaging techniques (e.g., MRI, spinal endoscopy) may help to develop
a gold standard for SNRB in CLBP-r patients. Finally, better insight into development, dura-
tion and the dynamics of neuroplastic changes is mandatory, especially in CLBP-r patients.
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A general introduction is given on the goal of this thesis with its main questions 
and on the conducted studies. In patients with (chronic) low back pain radiating to the leg
(CLBP-r) diagnostic segmental nerve root blocks (SNRBs) are performed to predict the 
outcome of surgical procedures and to identify the putative symptomatic spinal nerve.
Chronic back pain patients often lack a specific diagnosis and form a large population.
Questions rose with respect to the selectivity, sensitivity, specificity, and predictability of the
blocks in CLBP-r patients and thus with respect to their diagnostic value. Because there is in
CLBP-r patients no anatomical and functional gold standard to compare SNRB diagnosis
with, SNRBs should at least be a clinical entity with consistent clinical physiological effects.
The goal of this thesis is to study if SNRBs in CLBP-r patients without overt focal
neurological deficits generate consistent effects on sensory and motor function to be consi-
dered as a reliable diagnostic tool in CLBP-r patients.
To map these effects, studies are performed on the variability and consistency of:
• location and extend of paraesthesias elicited by electrostimulation at the segmental 
nerve root;
• location and extend of changes in sensory function;
• changes in motor function;
• epidural spread with SNRBs monitored with fluoroscopy, which is the most commonly
used imaging technique to guide SNRBs.
Chapter 2
In this chapter we discuss the diagnostic value of SNRBs in CLBP-r patients and the
most important problems related to pain diagnosis according the relevant literature. Many
uncertainties with respect to anatomical, neurophysiological and pathophysiological aspects
complicate the attempts to establish an equivocal diagnosis in these patients. Doubt seems 
to be justified to question the existence of “segmental pain”, i.e., radiating pain following a 
dermatomal pattern while no specific patho-anatomic diagnosis can be established.
Nevertheless, inflammatory and immuno-pathologic processes may cause radiating pain that
can hardly be observed by presently available imaging techniques as CT and MRI.“Segmental
pain” as conceptual framework should be reconsidered and the role of SNRBs still has to 
be established within that framework.
Chapter 3
We describe an observational prospective double blind study on the variability 
and interpretation of SNRB effects on the sensory function. Pinprick is used to assess 
dermatome related hypoaesthesia that developed after lumbosacral SNRBs in CLBP-r patients
without neurological deficits. Sites with maximum experienced pain, pre block elicited 
paraesthesias, and local anaesthetic induced hypoaesthesia with lumbosacral SNRB are 
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documented according to a map with standard dermatomes and a newly developed map
representing dermal overlap of segmental innervation.
After SNRB, a large variability in size and location of hypoaesthetic areas is found that
is much more variable than considered up to now. Elicited paraesthesias are more consistently
reproduced if related to the dermatome corresponding to the treated spinal segmental 
level. The spread of hypoaesthesia seems to be in keeping with the overlapping innervation
pattern of dermatomes and re-emphasizes the fact that dermatomes are more extensive 
than depicted in standard dermatomal maps. The understanding of the variability of
concomitant clinical physiological effects with SNRB as hypoaesthesia, elicited paraesthesias
and pain reduction in relation to the presumed dermatome, is improved when the overlap 
of neighboring dermatomes is taken into account. This is an important aspect with respect
to assessment of SNRB quality. Only electrical elicited paraesthesias are, if related to the 
corresponding dermatome, consistently reproducible.
Chapter 4
In this chapter, we present a case series of CLBP-r patients without overt focal neural
deficits undergoing L4 SNRBs in a prospective randomised controlled cross over fashion
with lidocaine and ropivacaine in equipotent doses. This study was conducted to assess 
changes in pre- and post block extend and location of hypoaesthesia.
Pre block hypoaesthesia is present in 70% of the cases but the patterns are not 
clearly dermatome-like. SNRBs do not have significant effects on sensory function within
prior existing alterations of sensory processing. Relating duration of complaints to extend
of hypoaesthetic skin areas suggest a tendency indicating that the presence and extend of pre
block sensory changes in CLBP-r patients are positively related to the duration of pre-existing
pain. No differences are found for SNRB effects on pain and changes in hypoaesthesia area
between ropivacaine and lidocaine.
The findings in this study are suggestive for the presence of pre block sensory 
function changes that are related to duration of pain. A co-founding that dorsal root ganglion
electrostimulation thresholds are lower when the number of painful dermatomes is higher,
supports the idea that neuroplasticity is present. The presence of these pain induced pre block
sensory changes influence the SNRB effects on the sensory function and complicate 
the assessment and interpretation of SNB effects. This limits the clinical value of SNRBs 
in CLBP-r patients without overt focal neurological deficit, who represent a major popula-
tion of chronic pain patients. If sensory function is evaluated with SNRB, net effects have 
to be assessed.
Chapter 5
Here we present a prospective randomised controlled cross over study conducted to
examine L4 SNRB effects in CLBP-r patients on pain and muscle force comparing lidocaine
and ropivacaine. We related pain reduction and changes in maximum voluntary myotomal
muscle force to each other to assess the role of pain and SNBs with respect to motor function.
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Although SNRBs do cause variably muscle force increases and decreases in the 
individual patients, the group maximum voluntary muscle force decreases in the painful
limb. However, patients who experience pain reduction, also if maximum pain was not in
dermatome L4, show a statistically significant pain reduction related increase of the maximal
voluntary muscle force. No differences are found for SNRB effects on pain and maximal
voluntary muscle forces between ropivacaine and lidocaine.
This study demonstrates that in CLBP-r patients, non-specific pain reduction induced
by local anaesthetic SNRB is associated with increased muscle force in musculature mainly
innervated by the treated corresponding spinal nerve. This finding is unexpected because
one would anticipate SNRB to decrease muscle force, which actually happens for the whole
patient group at the affected side. Pain reduction with SNRB, accompanied by muscle force
increase, happens independently of the presence of maximum pain in the corresponding
dermatome L4 and is therefore non-specific. This muscle force increase with block impres-
ses as dis-inhibition of pain induced muscle force loss. Supraspinal mechanisms such as
Diffuse Noxious Inhibitory Control (DNIC) are suggested.
Chapter 6
In this chapter we present a study concerning inadvertent epidural spread with SNRB
that may lead to decreased selectivity of the block and false positive outcome influencing the
clinical decision making. Systematic analysis of fluoroscopy guided epidural spread of local
anaesthetics mixed with contrast dye, of the position of the needle point in the intervertebral
foramen and assessment of the mutual relationship was not done so far.
In this prospective observational study, X-ray pictures with needle tip and contrast,
made before and after lumbosacral SNRBs with 0.5 ml of a radiopaque mixture, were analy-
zed by 2 investigators blinded for the patients’ background for epidural spread (L4, L5) or
spread to adjacent nerve roots (L4-S1).
Epidural spread occurs in 47% of the L4 and in 28% of the L5 blocks and inadvertent
spread to an adjacent nerve root is detected only in 3 blocks (L5 n=1, S1 n=2). For lumbar
SNRBs the needle is most frequently found in the lateral part of the upper half of the 
intervertebral foramen, but the rate of lumbar epidural spread is related to medial position
of the needle in the intervertebral foramen. In the cases with epidural spread to an adjacent
nerve root, medial needle position is found also. Thus, epidural spread decreases selectivity
and necessitates caution regarding the role of SNRBs in clinical decision-making.
Chapter 7
In chapter 7 the thesis findings are discussed. There is a large variability in the changes
of sensory and motor function induced by SNRB. Multiple factors, such as multisegmental
innervation of spinal structures, overlap of neighbouring dermatomes, chronic pain induced
neuroplasticity and epidural spread result in limited reliability of the blocks with respect 
to consistency and interpretation of effects. Of the described concomitant effects after 
SNRB only paraesthesias induced by electrical nerve stimulation show a consistent pattern,
potentially making these suitable for improving pain diagnosis and monitoring the 
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technical quality of SNRBs. The findings of this thesis do not support that SNRB, as 
presently used, is an adequate diagnostic tool to relate radiating pain in the leg in chronic
low back pain patients to a specific spinal segmental level. Future work should focus on distin-
guishing segmental pain from non-segmental (referred) pain by matching paraesthesias 
not only to pain at the stimulated level, but also with pain reduction induced by the nerve 
root block. Furthermore, the relationship between paraesthesias in irritated vs non-irritated
nerve roots needs to be established. Selectivity of the nerve root block should be improved to
reduce false interpretations of block outcome. Increasing the resolution of modern imaging
techniques (e.g., MRI, spinal endoscopy) may help to develop a gold standard for SNRB 
in CLBP-r patients. Finally, better insight into development, duration and the dynamics 







Hierin wordt een algemene introductie gegeven over het doel van dit proefschrift,
over de belangrijkste onderzoeksvragen en de uitgevoerde studies. Diagnostische segmentale
zenuwwortelblokkaden worden uitgevoerd bij patiënten met (chronische) lage rugklachten
met uitstraling naar het been om de uitkomst te voorspellen van een operatieve ingreep 
waarbij een ruggenmergszenuw ontlast wordt of om de vermoedelijke symptomatische 
segmentale ruggenmergszenuw te identificeren. Bij patiënten met chronische uitstralende
lage rugklachten kan vaak geen specifieke diagnose worden gesteld en deze patiëntengroep
vormt een grote populatie. Begrippen als selectiviteit, sensitiviteit, specificiteit en voorspel-
baarheid van segmentale zenuwwortelblokkaden bij deze patiënten roepen veel vragen op.
De vraag is nu wat de diagnostische waarde is van deze zenuwblokkaden bij dit type patiën-
ten. Omdat er bij patiënten met chronische uitstralende lage rugklachten geen anatomische
en functionele goudstandaard voorhanden is, waarmee het resultaat van een segmentale
zenuwwortelblokkade vergeleken kan worden, zou deze zenuwblokkade op zijn minst 
moeten leiden tot consistente klinisch-fysiologische effecten.
Het doel van dit proefschrift is om vast te stellen of segmentale zenuwwortelblok-
kaden bij patiënten met chronische uitstralende lage rugklachten stelselmatig effecten 
hebben op gevoel en spierkracht, zodat ze als een betrouwbaar diagnostisch instrument
beschouwd kunnen worden.
We voerden een aantal studies uit om te kijken naar de variabiliteit en consistentie
van de volgende effecten:
• lokatie en uitbreiding van paresthesieën (“gevoelsprikkels”), welke opgewekt werden door
middel van elektrische stimulatie van een ruggenmergszenuwwortel;
• lokatie en uitbreiding van veranderingen van de gevoelsfunctie;
• veranderingen van de spierfunctie;
• verspreiding van de injectievloeistof binnen de epidurale ruimte (de ruimte binnen 
de wervelkolom welke het harde ruggenmergvlies omgeeft en tevens de ruimte, die de 
ruggenmergszenuwwortels passeren op weg naar buiten).
Hoofdstuk 2
De diagnostische waarde van segmentale zenuwwortelblokkaden bij patiënten met
chronische lage rugklachten uitstralend naar het been en de belangrijkste problemen die 
zich voordoen bij het stellen van de diagnose worden besproken aan de hand van de meest
relevante literatuur.
Er zijn veel onzekerheden met betrekking tot anatomische, neurofysiologische 
en pathoanatomische aspecten waarmee we rekening moeten houden bij patiënten met 
chronische lage rugpijn met uitstraling naar het been. Daardoor kan het moeilijk zijn om
een eenduidige diagnose te stellen. Op basis van de huidige inzichten lijkt er gerede grond te
zijn om te twijfelen aan het bestaan van “segmentale pijn”, ofwel pijn die uitstraalt volgens het
patroon van een dermatoom (huidgebied dat door één ruggenmergszenuw geïnnerveerd
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wordt) zonder dat er een specifieke pathoanatomische oorzaak kan worden vastgesteld.
Desondanks kunnen er verklarende oorzakelijke factoren aanwezig zijn voor rugklachten
met uitstralende pijn, welke nauwelijks kunnen worden vastgesteld met de op dit moment 
ter beschikking staande beeldvormende technieken als CT en MRI. “Segmentale pijn” als
conceptueel denkraam zou herzien moeten worden en de werkelijke rol van de segmentale
zenuwwortelblokkade moet binnen dat kader nog steeds worden vastgesteld.
Hoofdstuk 3
In dit hoofdstuk beschrijven we in een observationele, prospectieve, dubbelblinde 
studie de variabiliteit en interpretatie van de effecten op de gevoelsfunctie, die veroorzaakt
worden door segmentale zenuwwortelblokkaden. Dit onderzoek werd gedaan bij patiënten
met chronische lage rugklachten met uitstraling naar het been zonder neurologische 
uitvalsverschijnselen.
Pinprick wordt gebruikt om dermatoom-gerelateerde gevoelsverminderingen vast te
leggen na lumbale en sacrale segmentale zenuwwortelblokkaden met een lokaal anestheti-
cum. De huidgebieden waar de meest ernstige pijn, paresthesieën en gevoelsvermindering
voor pinprick worden ervaren, worden in kaart gebracht. Hiervoor wordt een kaart gebruikt
met standaarddermatomen en een kaart waarop dermatomen worden weergegeven waarbij
rekening is gehouden met overlap van dermatomen.
Er wordt een grote variabiliteit gevonden in de grootte en lokatie van huidgebieden
met gevoelsvermindering. Deze variabiliteit is groter dan tot nu toe werd aangenomen.
Paresthesieën worden wel consistent ervaren in het dermatoom (zowel standaard als aan-
gepast), dat correspondeert met het niveau waarop de segmentale zenuw is gestimuleerd.
De verspreiding van de gevoelsvermindering lijkt samen te hangen met het patroon van 
dermatoomoverlap en benadrukt het gegeven dat dermatomen veel uitgebreider zijn dan
voorgesteld in de gemiddelde praktijk. De variabiliteit van de na de wortelblokkade optre-
dende klinisch-fysiologische effecten (gevoelsvermindering, paresthesieën en pijnreductie in
het dermatoom waarin de meeste pijn zit), lijkt beter begrepen te worden als we rekening
houden met de overlap met naburige dermatomen. Dit aspect is van groot belang voor de
interpretatie van segmentale zenuwwortelblokkaden. Alleen de door electrische stimulering
van de segmentale ruggenmergszenuwwortel opgewekte paresthesieën, zijn in het bijbe-
horende dermatoom goed reproduceeerbaar.
Hoofdstuk 4
In dit hoofdstuk presenteren we een reeks patiënten met chronische lage rugpijn 
met uitstraling in het been zonder tekenen van neurologische uitval, waarbij in alle gevallen
segmentale zenuwwortelblokkaden werden uitgevoerd op hetzelfde niveau (L4). In deze 
prospectieve, gerandomiseerde, gecontroleerde cross-over studie werden lidocaine en 
ropivacaine in equipotente doseringen met elkaar vergeleken. Doel was het huidgevoel voor 
pinprick vóór en ná het uitvoeren van de segmentale zenuwwortelbehandeling met elkaar 
te vergelijken.
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In 70% van de gevallen blijkt dat er vóór het aanbrengen van de wortelblokkade reeds
gebieden met gevoelsvermindering aanwezig is, echter zonder een duidelijk dermatomaal
patroon. Segmentale zenuwwortelblokkaden hebben géén significante effecten op de reeds
bestaande gevoelsveranderingen voor pinprick. Er is een trend gevonden dat, naarmate 
de pijn langer aanwezig is, de reeds bestaande gevoelsvermindering groter is en meer aan de
uiteinden van het been is gelokaliseerd. Tussen lidocaine en ropivacaine worden geen 
verschillen gevonden als het gaat om effecten van de segmentale zenuwwortelblokkaden op
pijn en gevoel.
De bevindingen van deze studie suggereren dat de aanwezigheid van de veranderin-
gen van de gevoelsfunctie vóór de wortelblokkade samenhangen met de bestaansduur van 
de pijn. Een bijkomende bevinding dat de paresthesie-drempels voor electrostimulatie van 
de segmentale zenuwwortel of van het dorsale zenuwwortel ganglion lager zijn wanneer 
het aantal dermatomen met pijn groter is, ondersteunt het idee dat deze verschijnselen 
toegeschreven kunnen worden aan neuroplastische veranderingen bij deze patiënten.
De aanwezigheid van pijn geïnduceerde pre-blok gevoelsveranderingen beïnvloedt de 
interpretatie van de effecten van de segmentale zenuwwortelblokkade op het gevoel. Het
beperkt de klinische waarde van de segmentale zenuwwortelblokkaden bij patiënten met
chronische lage rugpijn met uitstraling in het been. Verder moet, als de gevoelsfunctie wordt
geëvalueerd bij zenuwwortelblokkaden, altijd het netto effect (d.w.z. het verschil tussen de
metingen voor en na het blok) onderzocht worden.
Hoofdstuk 5
In dit hoofdstuk beschrijven we in een prospectieve, gerandomiseerde, gecontroleerde
cross-over studie de effecten van segmentale zenuwwortelblokkaden op niveau L4, uitgevoerd
met lidocaine en ropivacaine, op pijn en spierkracht bij patiënten met chronische lage 
rugpijn met uitstraling in het been. Om de rol van pijn en segmentale zenuwwortelblok-
kaden te evalueren voor de spierkracht, werden pijnvermindering en veranderingen in 
de vrijwillig maximaal opgewekte spierkracht binnen het overeenkomende myotoom aan
elkaar gerelateerd.
Ondanks dat segmentale zenuwwortelblokkaden een grote variabiliteit veroorzaken
in toename en afname van spierkracht bij de individuele patiënten, daalt de vrijwillig maxi-
maal opgewekte spierkracht gemiddeld voor de gehele patiëntengroep in het bijbehorende
myotoom in het been met de pijn. Echter, patiënten die pijnvermindering ervaren na het
blok, ook als de maximale pijn niet in dermatoom L4 zat, tonen een statistisch significante 
stijging in de vrijwillig maximaal opgewekte spierkracht, welke samenhangt met hun 
pijnvermindering. Kort gezegd: pijnvermindering na een L4 blok leidt tot toename van 
spierkracht in het bijbehorend myotoom, terwijl de maximale pijn niet in dermatoom L4
zelf hoeft te zitten. Er worden geen verschillen gevonden tussen lidocaine en ropivacaine voor
wat betreft de effecten van het blok op pijn en spierkracht.
Deze studie laat zien dat niet-specifieke pijnvermindering, door patiënten ervaren na
segmentale zenuwwortelblokkaden met een lokaal anestheticum, leidt tot een toename in de
spierkracht in spieren, die voornamelijk worden geïnnerveerd door de geblokkeerde zenuw.
9.4
Deze bevinding is verrassend, omdat men zou verwachten dat een zenuwblokkade leidt 
tot spierkrachtverlies, wat gemiddeld ook gebeurt voor de hele patiëntengroep in het been 
met pijn. Deze niet-specifieke toename van spierkracht na wortelblokkade kan worden 
geïnterpreteerd als opheffing van verlies van spierkracht, dat tevoren werd veroorzaakt door
de aanwezigheid van pijn. Het is denkbaar dat supraspinale mechanismen als “Diffuse
Noxious Inhibitory Control”, ofwel DNIC, hierin een rol spelen.
Hoofdstuk 6 
In dit hoofdstuk presenteren we een studie naar het vóórkomen van onbedoelde 
epidurale verspreiding van de injectievloeistof bij segmentale zenuwwortelblokkaden.
Epidurale verspreiding kan de selectiviteit van de wortelblokkade verlagen en tot fout-posi-
tieve uitkomsten leiden, hetgeen de klinische besluitvorming beïnvloedt. Een systematische
analyse van epidurale verspreiding van lokaal anestheticum met röntgencontrastvloeistof,
vastgelegd met behulp van röntgendoorlichting, waarbij gekeken wordt naar de naaldpositie
in het foramen intervertebrale en naar de relatie met epidurale verspreiding, is tot dusverre
niet gedaan.
In deze prospectieve en observationele studie werden vóór en ná injectie van 0,5 ml
röntgencontrastvloeistof röntgenfoto’s gemaakt, om de positie van de naaldtip in het foramen
intervertebrale en de verspreiding van contrastvloeistof te beoordelen. De foto’s werden 
onafhankelijk geanalyseerd door 2 onderzoekers die geblindeerd waren voor de patiënten.
Er werd onder meer gekeken naar epidurale spreiding (bij blokkade op niveau L4 en L5) 
en naar spreiding naar naburige ruggenmergszenuwwortels (bij wortelblokkade op  niveau
L4, L5 en S1).
Epidurale spreiding komt voor in 47% van de L4 wortelblokkaden en in 28% van de
L5 wortelblokkaden. Onbedoelde spreiding naar een naburige zenuwwortel wordt vastge-
steld na 3 wortelblokkaden (L5 n=1, S1 n=2). Bij de lumbale blokkaden wordt de naaldtip
meestal in het laterale deel van de bovenste helft van het foramen intervertebrale gevonden,
maar het vóórkomen van epidurale verspreiding hangt samen met een mediale positie van 
de naaldtip in het foramen intervertebrale. In die gevallen waarbij epidurale spreiding naar
een naburige zenuwwortel wordt vastgesteld, blijkt de naaldtip óók mediaal in het foramen
te zijn gepositioneerd.
Geconcludeerd wordt dat epidurale verspreiding de selectiviteit van het zenuw-
wortelblok verlaagt en dat voorzichtigheid geboden is ten aanzien van de rol van dit blok 
in de klinische besluitvorming.
Hoofdstuk 7
In dit hoofdstuk worden de bevindingen van dit proefschrift besproken, worden 
eindconclusies gegeven en worden aanbevelingen gedaan ten aanzien van studies die in de 
toekomst kunnen worden uitgevoerd.
Er wordt een grote variabiliteit gevonden met betrekking tot veranderingen van 
het gevoel en de spierkracht wanneer segmentale zenuwwortelblokkaden worden toegepast.
De consistentie en interpretatie van deze effecten wordt beïnvloed door vele factoren, zoals
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multisegmentale innervatie van de wervelkolom en overlap van naburige dermatomen,
pijn-gerelateerde neuroplasticiteit en verspreiding van het injectaat in de epidurale ruimte.
Van de onderzochte effecten is alleen het opwekken van paresthesieën goed reproduceerbaar,
als het gaat om de relatie tussen de gestimuleerde zenuwwortel en het bijbehorende 
dermatoom. Het verdient aanbeveling om elektrisch opgewekte paresthesieën zowel voor als
na het blok vast te stellen. Dit komt de kwaliteit van het wortelblok en dientengevolge ook het
diagnostisch proces ten goede.
In de toekomst zou men zowel paresthesieën als pijnvermindering moeten relateren
aan het pijnlijke spinale niveau om een onderscheid te maken tussen segmentale en 
niet-segmentale of gerefereerde pijn. De relatie tussen elektrisch opgewekte paresthesieën 
bij geïrriteerde en niet-geïrriteerde zenuwwortels zou moeten worden onderzocht. De 
selectiviteit van de zenuwwortelblokkade moet worden verbeterd om de kans op foute 
interpretaties van effecten te verminderen. Ten aanzien van de diagnostiek zou het verhogen
van de resolutie van moderne beeldvormende technieken zoals MRI en spinale endoscopie
kunnen bijdragen aan de ontwikkeling van een goudstandaard voor de uitkomst van 
zenuwwortelblok bij patiënten met chronische lage rugklachten met uitstraling naar het been.
Ten slotte is, vooral met betrekking tot rugpijnpatiënten, meer inzicht gewenst in de 
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Onderzoek doen betekent een proces ingaan waardoor je groeit. Je ontwikkelt 
kennis, analytisch denk- en abstractievermogen en komt tot nieuwe denkwijzen. Je ondergaat
vele momenten van verwondering en leert om te gaan met tegenslagen. Onderzoek doen 
verrijkt je. Ik heb dit al die jaren met veel plezier gedaan en zal er ook nooit mee klaar zijn.
Gedurende dit proces heb ik hulp gehad van anderen. Veel mensen hebben hierin bijgedra-
gen in actieve, passieve, bewuste of onbewuste vorm. Deze mensen ben ik dan ook heel 
dankbaar voor wat zij voor mij hebben kunnen betekenen.
In chronologische volgorde wil ik graag mijn dank uitspreken.
Allereerst aan mijn opleiders. Het zijn er diverse. Jan Crul nam mij aan. Herman
Beneken Kolmer leidde mij tussentijds op en Leo Booij zei toen ik “de periferie” in ging om
te werken bij een toen al uitstekende maatschap Anesthesiologie in Oss, dat hij mij nog 
wel verwachtte terug te zien in “de Academie”.
Mijn interesse voor pijnbestrijding werd gewekt toen ik mijn stage pijnbestrijding
deed in mijn opleidingstijd bij Ben Crul, die toen net uit de periferie was terugkomen om
pijnbestrijding verder te ontwikkelen in het St Radboud ziekenhuis. Hij was het die mij in
1995 vroeg om deeltijds voor het Pijn Kennis Centrum (PKC) in Nijmegen te komen werken.
Inmiddels was ik al in Oss begonnen, in het St. Anna ziekenhuis. Daar heb ik geleerd
het vak uit te oefenen, anesthesiologie en pijnbestrijding, en een betere maatschap kon ik mij
niet wensen met als maten Karel Slegers, Huub Spoormans en Gerard Braak. Beste Karel,
Huub en Gerard, met jullie werken is uiterst plezierig en waardevol geweest. Jullie  hebben 
een open instelling, zijn constructief en collegiaal. Niet voor niets zei de toenmalige directeur
van het St. Anna ziekenhuis, Sijbrand Gerritse, dat de maatschap anesthesiologie de parel 
van het ziekenhuis was toen hij mij belde om me te vertellen dat ik uitverkoren was na 
de sollicitatie procedure. En niet voor niets behoort de maatschap anesthesiologie in 
ziekenhuis Bernhoven tot de best functionerende maatschappen in Nederland én huisvest 
hun praktijk sinds 2004 ook arts-assistenten anesthesiologie voor hun perifere deel van de
opleiding. Ik heb ook de samenwerking na de fusie per 1 januari 2000 met de maatschap in
Veghel (met collegae Hans van der Zee, Victor van Cauter, Peter Baaijens, Eric van Ark en later
met Marcel Schenkels) voornamelijk als prettig ervaren. De maatschap anesthesiologie heeft
altijd mijn onderzoek gesteund en mede dank zij jullie heb ik al mijn patiënten kunnen inclu-
deren in de diverse studies. Bij 3 van die studies hebben Marianne Bijman, Esther van Eggelen
en Marc van de Heijden mij bijzonder geholpen door hun afstudeer opdrachten af te stem-
men op mijn onderzoek. Hun rollen als onafhankelijke onderzoekers is hierbij onmisbaar
geweest. Verder gaat mijn dank uit naar Marlies Baas, Geertje Deerns, Trudy Berns en Estella
Meulendijks. Mede door jullie goede zorgen liepen de spreekuren en pijnbehandelingen in Oss
“als een trein”. Mede dankzij jullie heb ik al mijn onderzoekspatiënten kunnen behandelen.
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Met de hulp van Gerard en Karel heb ik mij in Oss vele pijnbestrijdingstechnieken
eigen gemaakt. Jullie beiden zijn praktisch doch kritisch ingesteld. Pijnpatiënten behande-
len deden we verder onder anderen samen met Fons Sijbers, klinisch psycholoog en Hendrik-
Jan Mennema, neuroloog. Beiden waren verbonden aan het multidisciplinaire pijnteam dat
al sinds ongeveer 1980 functioneerde in Oss. Beste Fons en Hendrik-Jan, jullie behoren tot 
de professionals die vanaf het eerste uur bij pijnbestrijding betrokken waren. Veel tijd 
hebben wij samen doorgebracht, ook om ná de pijnteambesprekingen samen bomen op te
zetten over pijn, patiënt, mens, samenleving en vele onbegrepen zaken. Holistisch denken
was in die tijd al gemeengoed. De basis voor mijn huidige visie op pijn heb ik in die tijd voor
een groot deel met jullie ontwikkeld.
In mijn Osse periode ben ik dus begonnen met het opzetten van het onderzoek waar
deze thesis het resultaat van is. Ben Crul gaf me destijds de gelegenheid om deel te nemen aan
diverse projecten van het Pijn Kennis Centrum Nijmegen en om mijn ideeën aangaande 
mijn onderzoek vorm te geven onder de vlag van het PKC Nijmegen. Beste Ben, jouw 
faciliterende rol is van groot belang geweest, niet in de laatste plaats ook, omdat jij als 
hoogleraar en voorvechter van pijnbestrijding sterk hebt bijgedragen in de toenemende 
aandacht voor pijn en pijnbestrijding.
Vervolgens kwam ik in contact met Gerbrand Groen uit het AZU. De eerste impuls
hiervoor werd gegeven tijdens een uiterst aangenaam pijncongres op Tenerife. Beste Gerbrand,
heel veel uren spraken wij over pijn en onderzoek, maar daar bleef het niet bij. Zo zitten 
we samen ook in meerdere besturen van organisaties die actief zijn op het gebied van pijn 
en pijnbestrijding. Vanuit veel onderzoek- en onderwijservaring, met goede pijptabak of
een goede sigaar erbij, ben je altijd een onnavolgbare gids geweest. Jouw vlijmscherpe 
analytische vermogen en je talent om een boodschap glashelder weer te geven zijn voor mij
altijd van grote steun geweest. Jouw inhoudelijke bijdrage in dit werk is van onschatbare
waarde. Een mooie vriendschap is hier bovendien uit voortgekomen die ik altijd zal 
blijven koesteren.
Nadat Oliver Wilder-Smith naar Nijmegen was gekomen is al snel een vruchtbare
samenwerking tot stand gekomen. Oliver, jouw onderzoekservaring en visie brachten 
andere dimensies in mijn onderzoek. De dynamiek van pijn als proces kreeg een betere plaats.
We delen veel in de visie over pijn en onderzoek en over het faciliteren van voorwaarden 
om pijnonderzoek kwalitatief naar grotere hoogten te brengen.“Making pain visible” is voor
jou een hoger doel en verschaft ook mijn onderzoek een goede basis. Inzicht verkrijgen in
het chronisch worden van (rug)pijn zal ons nog lang bezig houden!
Robert van Dongen vroeg als hoofd van de afdeling pijnbestrijding in 2002 of er bij 
mij misschien toch interesse was om terug te keren naar “het Radboud”. Beste Robert, van 
deze switch heb ik geen spijt gehad, al had ik het goed in Bernhoven. Vele uitdagingen 
wachtten mij tot nu toe en wachten mij nog steeds in Nijmegen en ik ben je dankbaar dat je
mij de kans bood om deze uitdagingen aan te gaan. We hebben een prettige samenwerking en
dat is voor een groot deel ook aan jou te danken.
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Directe collegae Monique Stegers, Will Gerrits, Lieven Dick en sinds kort ook Willem
Brinkert en, belangrijk, de komst van Kris Vissers als hoogleraar Palliatieve Zorg dragen 
in belangrijke mate bij aan een goede werksfeer binnen het pijncentrum. Het bieden van 
en het verbeteren van patiëntenzorg, het samen verder structureren van de afdeling en het
opleiden van assistenten en jonge stafleden behoort tot de mooie uitdagingen van ons vak.
De rol van de pijn-verpleegkundigen is prominent binnen ons pijncentrum. Vooral
Paul Verstegen, maar ook Lily Frederix en Mieke Luckers wil ik (zonder de anderen te kort te
willen doen!) bedanken voor hun inspanningen bij het mee opzetten van epiduroscopie in het
UMC St Radboud. Daarnaast is de steun van de secretariaten van het Pijn Centrum en het
Pijn Kennis Centrum voor ons functioneren onmisbaar. Vooral Anne van Muijen, maar ook
Anita Jacobs voor het pijncentrum en Anneke Brand (tot 1 februari 2006) en Dedi Rijkers
voor het PKC zijn bijzonder behulpzaam en organiseren het reilen en zeilen van allerlei 
patiënten- en kennisactiviteiten. Marianne van Leeuwen en Jeske Bongers nemen daarbij nog
een speciale rol in als het gaat om organisatie en het zetten van “de puntjes op de i”. Aansturing
van het PKC maar ook projecten als preventie van chronische rugklachten, waarin we samen
werken met o.a. Eric van Rijswijk, huisarts, en Andrea Evers, medisch psychologe, is zonder
jullie onmogelijk. De komende tijd, zullen we samen met de overige medewerkers van het
PKC Nijmegen de kennisactiviteiten verder gestalte geven.
De afdeling anesthesiologie wordt geleid door Gert Jan Scheffer. Beste Gert Jan,
jouw enthousiasme en visie om de afdeling verder vorm te geven, samen met de aanwezigheid
van veel goede mensen bieden ons allen goede kansen om een mooie toekomst tegemoet 
te gaan. Hoewel pijnbestrijding niet jouw primaire vak is, begrijp je als geen ander dat 
weefselschade, nociceptie en pijn onlosmakelijk met elkaar verbonden zijn en daarmee ook
anesthesiologie en pijnbestrijding. Samen met Marcel Hasenbos (Chef de Clinique) en Dirk
van Diejen (de Chef de Poli-Clinique), zal ik de komende tijd graag mijn bijdrage leveren
als mede-Chef de Clinique om van onze grote afdeling een nog mooiere te maken, waar alle
stafleden, arts-assistenten en overige medewerkers, maar ook algemene en wetenschappe-
lijke ontwikkelingen goed tot hun recht komen. Samen met al onze collega stafleden moet het
gaan lukken om de komende jaren onze missie succesvol te maken. En….hierbij is voor ons
functioneren als Chef de Clinique de bijdrage van Mariska van de Berk onmisbaar!
Speciale dank gaat uit naar mijn paranymfen, Eric van Laarhoven en Karel Slegers.
Als eerste Eric, vriend, studiegenoot, vroegere huisgenoot, dispuutgenoot, getuige bij mijn
huwelijk, orthopedisch chirurg (en ook nog opgeleid door mijn schoonvader!): Beste Eric, bij
onze vriendschap doen tijd en afstand er niet toe. Friendship forever! Jouw vriendschap is mij
altijd bijzonder waardevol geweest. En Karel, collega anesthesioloog, meer dan maat in de
maatschap: Beste Karel, met jou volgde ik de röntgenhygiëne cursus al voordat ik in Oss 
als anesthesioloog was begonnen. De toon was gezet. Jíj gaf me thuis op de keukenvloer een
epiduraal injectie toen mijn rug niet meer mee wilde doen en ik letterlijk geen millimeter
meer vooruit kon en…. het hielp! Overigens had Gerard dat kunstje ook al eens met succes
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geflikt, maar dan in het ziekenhuis, netjes aan de monitor. Het voordeel hiervan is dat ik het
vak pijnbestrijding ook van de andere kant heb mogen ervaren...
Vrienden Ben Prins en Bart Poierrié hebben beide op eigen wijze een voor mij belang-
rijke rol gespeeld in de totstandkoming van mijn proefschrift. Vrienden ben je door dik en
dun, in betere en slechtere tijden. Ik ben dankbaar dat we elkaars vrienden mogen zijn. Dank
wil ik ook uitspreken aan Jolanda van Gent, voor haar bijdrage aan mijn manuscript.
Maar nu de allerbelangrijkste mensen voor mij: Lieve Brigit, de vrouw van wie ik hou,
mijn allergrootste steun en toeverlaat en “vriend”. Je dacht en zei vaak: joh, kijk nou eens
goed naar al je activiteiten, maak keuzes. Soms doe ik dat ook, maar als bezige bij zit ik nu een-
maal zó in elkaar, dat mijn kar behoorlijk geladen moet zijn om me lekker te voelen. En met
deze kar ben ik altijd op pad en jij geeft me de ruimte daarvoor. Alles wat ik doe, inclusief mijn
activiteiten buiten mijn werkgebied, heeft mij mede gevormd en dat kost tijd.“Onderweg” zijn
is al een genot…. En in wat mij gevormd heeft, heb jij wel een heel belangrijke rol gespeeld.
Overigens, als geliefde, levenspartner, moeder, huismanager, tandarts met eigen praktijk en
wedstrijdsecretaris, en dan nog met al de rollen die je daarbuiten nog bekleedt, kun jij er ook
aardig wat van. Je bent óók nog een goede sparring partner. Dank je voor alles.
Wouter, Geert, Stijn en Bas. Jullie zijn een ongelooflijk mooi stel jongens en rakkers bij
elkaar. Met veel energie en vele talenten zijn jullie rijkelijk gezegend. Gedurende al de jaren
van mijn onderzoek hebben jullie ook wel interesse in mijn activiteiten gehad. Echter, de vele
uren thuis achter mijn computer maakten mij er niet altijd gezelliger op. Jullie betrokken-
heid in de vorm van “hé pap, wanneer ben je nou eens klaar?”, en, “wanneer is het feest?”,
en…. “je promoveert toch wel onder schooltijd, hè?” kan ik wel waarderen. Helaas Bas, het is
woensdagmiddag geworden.…Misschien zijn jullie je het niet bewust, maar ik leer veel van
jullie. Mij spiegelen is iets waar jullie je niet van onthouden als jullie het nodig vinden. Dank
jullie wel hiervoor.
Last but not least: heel veel dank gaat uit naar mijn ouders en schoonouders, van wie
in 2002 mijn schoonmoeder helaas is ontvallen na een lange ziekteperiode: Jullie hebben mij
gefaciliteerd. Ook zonder jullie zou ik niet zijn wie ik ben. Met een gezonde en gelukkige
jeugd werd mij een basis geboden met vele kansen. Eén van die kansen is een wetenschap-
pelijke ontwikkeling waar ik met volle teugen van geniet.
Als laatste zijn er eigenlijk nog zoveel meer mensen aan wie ik dank verschuldigd ben.
Broers en zussen van beide kanten met aanhang, andere familie leden, veel goede vrienden en
vriendinnen, Lions, Tafelaars, Olifanters en nog vele anderen. Ook door jullie vind ik de 
verrijking, rust en energie om te doen wat ik doe. Dankzij iedereen die ik in dit woord heb
genoemd en vele anderen die niet bij naam zijn genoemd is onderzoek doen en promoveren
een feest!!
André Wolff
Nijmegen, 10 mei 2006
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Grünenthal
Grünenthal is van oorsprong een Duits bedrijf, gevestigd in Aken, dat in 1845 is
gesticht als zeepfabriek. Het is sinds 1888 100% eigendom van de familie Wirtz. Uit deze
fabriek ontstond in 1946 het farmaceutische bedrijf Grünenthal. De zeepfabriek bestaat
voort als cosmeticabedrijf (Mäurer & Wirtz, o.a. bekend van het merk Tabac). Aanvankelijk
worden medicinale producten op basis van plantenextracten en schimmels bereid zoals 
penicilline en digitalis. Vandaag de dag is de productie van antibiotica nog een belangrijke 
activiteit.
Tramal wordt in 1963 door Günenthal gesynthetiseerd en gekarakteriseerd als een
effectieve pijnstiller. Omdat de firma niet actief is in pijnbestrijding duurt het tot 1973 voor
het is uitontwikkeld en beschikbaar is voor patiënten. Met de ontdekking van endorfinen en
opioid receptoren in de 70’er jaren neemt de belangstelling voor het unieke werkingsprofiel
van tramadol sterk toe. In de 80er jaren beginnen artsen het met groot succes in te zetten bij
zeer verschillende vormen van pijn. Hierna wordt Tramal geregistreerd in bijna alle landen.
Tramal is sinds 1998 wereldwijd het meest voorgeschreven opioïd.
De strategie van Grünenthal is om een zelfstandig, onafhankelijk familiebedrijf te 
blijven met een oriëntatie op de lange termijn. Ongeveer 15% van de omzet wordt gestoken
in eigen Research & Development, aangevuld met strategische allianties (b.v. Takeda, Johnson
& Johnson) en in-licenciering van producten, waar gewenst. Pijnbestrijding is het allerbe-
langrijkste aandachtsgebied van de firma.
De laatste jaren heeft Grünenthal met succes Zaldiar®, een combinatie van paraceta-
mol met tramadol op de markt gebracht. Daarnaast is zojuist ClaroSip®, een klassiek antibi-
oticum in een innovatieve kindertoedieningsvorm, en Colistin®, een niche-antibioticum bij
de behandeling van Cystic Fibrosis beschikbaar gekomen. De komende jaren wordt Transtec®,
een matrix patch met het opioïd buprenorphine, en een product voor de behandeling 
van postherpetische neuralgie verwacht. Als opvolger voor tramadol zijn thans een 5-tal sub-
stanties in fase 2 van ontwikkeling, die allen een multiple mode of action hebben. Daarnaast
wordt op het gebied van orale anticonceptie en antibiotica nieuwe producten verwacht.
Grünenthal heeft eigen vestigingen Zuid-Amerika, Mexico, West & Midden Europa




Kosterijland 70-78, 3981 AJ Bunnik
tel. 030-6046370, fax. 030-6046912
www.grunenthal.nl, www.grunenthal.com
Mijn dank gaat uit naar de volgende co-sponsoren, 











André P. Wolff is anesthesiologist and consultant in pain medicine. His interest in
pain, patients suffering from pain and pain treatment inspired him to try bringing more
light into the darkness of pain for patients suffering from chronic radiating low back
pain. André P. Wolff was born in 1959 and currently works as head of the Pain Knowledge
Centre in Nijmegen and as chef de clinique at the Institute for Anesthesiology at the
Radboud University Nijmegen Medical Centre.
Establishing a clear diagnosis can be complicated in a large population of patients
suffering from chronic radiating low back pain. Improved insight into the value of
Segmental Nerve Root Blocks should bring us further in understanding underlying
mechanisms in these patients, which is essential to raise the efficacy of their pain treat-
ment. The author has performed various studies on the role of lumbosacral Segmental
Nerve Root Blocks in patients with chronic radiating low back pain. The studies are 
interesting and the results are surprising. They challenge present-day medical science
and care givers, active on the area of pain, to change the historical and current opinions
with respect to diagnosis, treatment and clinical decision making.
